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Abstract 
CHRISTOPHER M. SEAGLE:  Metabolomics Footprinting of Three Dimensional 
Bioreactors with Applications to In-Cell NMR 
(Under the direction of Jeffrey M. Macdonald, Ph.D.) 
 
Electrostatic devices for the manufacturing of cell encapsulations were 
constructed and used to form spherical alginate encapsulations containing 
hepatocytes, hepatic progenitor cells, mixed hepatic populations, and  Escherichia 
coli.  The encapsulations were tested for cell viability, cell functionality, respiration, 
and encapsulation architecture.  A novel high through-put NMR method was used to 
test serial media extractions from multi-coaxial bioreactors to determine metabolic 
function of human hepatic cell encapsulations over a 30 day period.  These tests 
revealed that by day five, lactate decreased below detection limits while glucose 
concentrations did not significantly change indicating aerobic metabolism.  Evidence 
of system perturbation and recovery following ammonia spiking of superfused media 
was also observed along with glutamine metabolism indicating urea cycle activity.  
These NMR results are the first demonstration of an assay to monitor the full 
spectrum of metabolites found in ex vivo encapsulated hepatic cell culture media for 
determination of consumption and production rates.   
Improvements to the NMR method were introduced to accommodate for 
evaporative loss and allow for more precise determination of actual metabolite 
consumption of media constituents and production of metabolites.  This new 
approach was used to compare metabolism differences between three-dimensional
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closed loop bioreactors and classic two-dimensional cultures to test the hypothesis 
that the more efficient 3D bioreactor will facilitate aerobic metabolism compared to 
2D cultures.  This will be reflected by consumption of aerobic nutrients, such as 
glutamine and alanine, and anaerobic production of lactate.  Based upon differences 
in metabolism of glucose and other energy sources, these studies seek to also test the 
hypothesis that traditionally observed oxygen levels (95%) in 3D culture studies are 
excessive for hepatocytic function.  
The tools of encapsulation based metabolomics were adapted to in-cell 
protein conformation studies using Escherichia coli.  Preliminary findings, while 
inconclusive, suggest that encapsulation based studies can eliminate confounding 
extracellular signals in NMR studies.
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 1 Introduction and Background 
 
1.1 Clinical and Research Challenges in Hepatology 
 
The liver is the largest internal organ of the human body responsible for a set 
of complex tasks including synthesis of biochemicals (bile, cholesterol, amino acids, 
coagulants,  filtration of the blood, metabolism and storage of energy sources 
(carbohydrates, proteins, fats, and lipids), storage of vitamins (vitamin A, D, and 
B12), and building materials for tissues [1].  The complexity of these functions poses a 
tremendous challenge for researchers wishing to study the liver or any of its 
functions while maintaining the aggregate functionality of the organ within 
reasonable physiological parameters.  Such research-oriented issues have historically 
been encountered in university and academic research settings but increasingly are 
being found in industries, including pharmaceutical research and development, 
where design of hepatic model systems for metabolic and toxicological testing of new 
drug compounds is becoming more prevalent.   
From the clinical perspective, liver complexity presents a challenge second 
only to that of availability of transplantable organs.  Improvements in automobile 
safety combined with increased life expectancy have led to a situation where 30,000 
U.S. patients die of liver failure while waiting for a liver transplant annually [2].  In 
short, the present organ availability problem is an inability of supply to meet
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demand.  In this environment where availability of suitable livers is a clear limit in 
the clinical equation, it is important to consider that liver failure patients may be 
sustained with only 20% of a functioning liver which would be approximately 300 
grams (g) [3].  In an effort to provide hepatic functionality to patients awaiting 
transplant organs, a variety of extracorporeal bio-artificial liver (BAL) devices have 
been considered and tested [2, 4-9].  The following discussion will elucidate methods 
and material designs relevant to furthering progress in both the research and clinical 
areas of hepatic research in BALs.   
Using nuclear magnetic resonance (NMR) technology, metabolic analysis of 
media streams from BALs specifically monitoring chemical constituents and 
concentrations was conducted.  The BALs were prepared with hepatic cells isolated 
from human cadaver livers in gels or encapsulations through use of an electrostatic 
encapsulation device developed as part of this project.  The long-range goal for such 
encapsulations is the development of stable hepatic cultures that can perform a 
partial or full range of hepatic physiological functions for both research and clinical 
applications.  Such encapsulations may provide long-term storage of hepatic cells, 
opportunities to amplify cells within a bioreactor environment, a reduction in 
mortality for patients experiencing liver failure, possible solution to the need for 
immunosuppressive therapy required with transplants, and a decrease in research 
costs associated with pharmaceutical development.   
New industrial perspectives are forcing pharmaceutical management to 
rethink target selection and validation methods, especially emerging low-cost 
biological modeling systems [10].  This trend is the result of increasing research and 
development costs which have more than doubled from an average of $316 million 
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for the decade of the 1980s to $802 million for the decade of the 1990s in inflation 
adjusted dollars [11].  Furthermore, many in the pharmaceutical community, 
including the FDA, argue that diminishing submissions of New Molecular Entities 
(NME) are the combined result of these substantially higher research costs in an era 
when most experts agree that the less complicated solutions and those achieved at 
lower research costs have largely been exhausted [12].  Bioreactor modeling of 
disease states coupled with high-throughput metabolomic studies using NMR 
technology may prove to be a cost-effective screening resource for determining 
metabolism and toxicity effects of lead compounds in the search for new 
pharmaceutical products [13]. 
 
1.2 State of Bioartificial Liver Research 
 
Several research groups have proposed different models for BALs.  The 
designs include two-dimensional (2-D) plates with cells grown on matrix and many 
varieties of three-dimensional (3-D) bioreactors with superficially attached cells, 
sandwiched cells, and/or cells secured in gels or permeable compartments.  2-D 
bioreactors are effectively cultured hepatocyte monolayers with the addition of 
media or plasma flow across the cell surface or permeable membrane separating the 
flow and monolayer.  While hepatocytes have performed for longer than two weeks 
in 2-D bioreactors, the large dimensions for a flat surface in order to generate 
sufficient surface area are a disadvantage when compared to 3-D systems [14].  An 
important design consideration for bioartificial liver devices must be the fact that 
hepatocytes maintain differentiation through attachment to extracellular matrix and 
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cell-to-cell interaction.[15]  For this reason, success achieved in renal support 
devices using cell suspension devices do not translate to hepatic devices as 
determined by diminished oxygen consumption of suspended hepatocytes [16, 17].   
 
1.3 Woven Hollow-Fiber Bioartificial Liver 
 
One of the earliest successes in the field of 3-D liver bioreactors occurred in 
1975 when Wolf and Munkelt successfully cultured hepatocytes in a hollow-fiber 
bioreactor system while monitoring bilirubin conjugation [18].  Contemporary 
developments in the hollow-fiber bioreactor field by Gerlach have resulted in 
systems having discrete fibers containing cells, nutrient flows, gas flows, and waste 
flows [19].  Such 3-D designs demonstrate attention to detail in the spatial 
arrangement to ensure adequate oxygen concentrations and nutrient concentrations 
but seem limited in the ability to scale-up to due to the need for elaborate networks 
of fiber tubules. 
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Figure 1-1 
Hollow fiber bioreactor model 
 
1.4 Coaxial Bioreactors for Bioartificial Liver 
 
Coaxial bioreactors have geometries which mimic the dimensions of the liver 
acinus.  The natural geometry of the liver includes a central venule, hepatocytes, and 
a collection of hepatic triads each having a portal venule, hepatic arteriole, and bile 
duct (see Figure 1-2, right side).  Coaxial bioreactor designs utilize concentric 
cylinders that serve as semi-permeable membranes allowing for nutrient and gas 
exchange between compartments while retaining cells in a space having a 500 
micron radial distance similar to the architecture of the liver.  Coaxial bioreactor 
designs better approximate the structure of a liver acinus but are just as susceptible 
to fouling of semi-permeable membranes over time as compared to other bioreactor 
designs [4].  
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1. Outer Fiber
2. Hepatocytes
3. Inner Fiber-Media
4. Extracellular
Compartment
5. Gas
Central Venule
Hepatocytes
Triad-
•Portal Venule (blue)
•Bile Duct (green)
•Hepatic Arteriole (red)
500µm
500µm
 
Figure 1-2 
Structural comparison of coaxial bioreactor and liver acinus 
 
The multicoaxial bioreactor (MCB) name is taken from the multi-tube 
architecture in which all tubes share the same axis of symmetry.  The MCB mimics 
the acinus in dimension and can mimic the oxygen profile which exists as free 
oxygen drops from 10 mmHg in the vicinity of the triad to 3 mmHg at the central 
venule [20]. 
While other designs exist, the two described to this point illustrate the need 
for appropriately sized architecture and potential problems with scaling and 
membrane fouling.  Ultimately, bioartificial liver designs should satisfy three points 
for consideration as practical tools for both clinical and basic science use:  
1. Bioreactors should provide stable environments for  
7 
2. physiological function of the tissues supported in a 
3. scalable model to allow for organ-sized constructs. 
 
1.4.1 Traditional Clinical Methods for Determination of Liver 
Function 
 
No single laboratory test is sufficient to provide a complete estimate of the 
function of the liver for every clinical situation.  An array of biochemical tests are 
employed clinically, therefore, to assess the many functions of the liver and to 
evaluate patients with suspected or established liver disease.  Liver function panels 
usually consist of aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), gamma-
glutamyltransferase (GGT), bilirubin (total and conjugated), albumin, transthyretin 
(prealbumin), and prothrombin time [21, 22].  ALT and AST are both indicators of 
liver cell death.  While ALT is largely found in the liver and kidney, ALT is not found 
exclusively in the liver and also may be found in the heart and other muscle tissue.  
Therefore, blood tests using ALT must be considered as total systemic measures 
[23].  LDH measures are less specific in terms of assessing liver damage, except in 
cases of ischemic liver injury where LDH levels are quite elevated [24].  In all cases, 
the most common liver function tests are limited to measures of injury or cell death.  
What may prove more beneficial for both clinical and basic science use in the future 
are functional assays which explore specific metabolic function by assessing the 
concentration of a host of chemical species related to liver health in parallel.  These 
tests would rely clinically on blood, serum, or urine analyzed by NMR resulting in 
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systemic measures of the compounds of interest.  However, through the use of 
bioreactors, the basic science use of such tests may exploit the isolated function of 
liver cells or other tissue types to determine organ specific metabolic activity. 
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2 Development of Encapsulator and First NMR 
Methods for Media Analysis 
 
2.1 Rationale and Goals 
 
Experiments were conducted with a focus on developing a matrix 
encapsulation system that could be used to mass produce spheres containing 
functioning cells.  Encapsulations may provide stable microenvironments for cellular 
growth, proliferation, and differentiation while shielding the contained cells from 
shear forces associated flow environments and may provide an immuno-protective 
barrier to recipients of cells implanted in encapsulated form.  Organized in 3D 
systems, such encapsulates can be studied by measuring metabolites in the media 
effluents from traditional culture plates and bioreactors.   
The encapsulations used in experiments described in this chapter included 
either cells from murine hepatic isolation or Umix® human hepatic cell mix (Vesta 
Therapeutics, Durham, NC).  Functional testing was conducted on the media 
streams taken from MCBs containing encapsulations using NMR methods developed 
in the course of this project.  Imaging of encapsulations was also performed to 
observe bead stability, cell migration, and cell viability as a function of time.   
Specifically, the goals of this research were to accomplish the following:
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1. Develop an inexpensive system for the encapsulation of large quantities 
of cells into spherical matrix. 
2. Demonstrate that encapsulated hepatocytes and/or cell mixes 
containing hepatocytes have similar metabolic function when 
compared to hepatocytes and/or cell mixes containing hepatocytes 
grown in conventional matrices. 
3. Establish the time course of survival of encapsulated hepatocytes 
and/or cell mixes containing hepatocytes. 
4. Establish a high through-put NMR metabolomic method for analyzing 
liver function as compared to traditional testing methods which tend to 
focus on measures of liver death. 
 
2.2 Development of Electrostatic Encapsulation Device  
 
In these studies, encapsulation of the cells was utilized for maintaining large 
numbers of cells within a confined hydrogel architecture which would provide 
protection from shear forces while still allow for diffusion into and out of the 
construct.  The guidelines for encapsulation materials and geometry were initially 
established as the following: 
1. Matrix material should be biocompatible.  No materials should be used 
that would be toxic to contained cells or tissues that encapsulations 
may be implanted into/onto. 
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2. Encapsulation geometry should be spherical.  Spherical geometry 
should allow for encapsulations to stack in regular patterns while 
providing space between adjacent encapsulations for media flow. 
3. Encapsulate radius should be no greater than maximal gas diffusion 
distance into the encapsulation.  This standard should prevent necrotic 
and apoptotic products resulting from an anoxic or hypoxic core from 
affecting more superficial viable cells in the encapsulation. 
 
2.2.1 The value of spherical encapsulations in a limited 
diffusion distance environment 
 
One of the inherent difficulties in the development of bioartificial organs is 
designing structures that provide environments that mimic in vivo conditions.  
Diffusion distance in bioartificial tissues and systems is one such challenge.  While 
scalability of a system is often viewed as one of the success measures in tissue 
engineering, size and scalability are often restricted by the maximum distance that 
nutrients can diffuse or penetrate into tissue or matrix from a media flow.  The 
nutrient possessing the smallest diffusion coefficient, therefore, determines the 
maximum measurement available for determining distances between cells and 
nutrient sources in a bioartificial tissue or organ design.  In the case of the liver, 
natural architecture reveals that convective flow channels are separated by a distance 
of no more than 100 microns (µm) [1].  This relatively tight packing of hepatocytes in 
a highly channeled structure ensures adequate blood flow to the liver which is 
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essential when considering that in rats, for example, the liver uses between 1/5 and 
1/3 of total body oxygen consumption [2]. 
Historically, the problem presented by the oxygen diffusion coefficient has 
resulted in bioreactor designs with distance suitable to provide appropriate oxygen 
concentrations to cells but challenged where scalability is concerned.  A possible 
solution that provides reasonable proximity between cells and nutrient rich media 
while also allowing for greater ease of scalability utilizes spherical encapsulations of 
cells in permeable hydrogels superfused with media.  Such a system would employ 
uniformly sized spheres such that a three-dimensional array of spheres would allow 
for media flows to pass through the spaces created between adjacent spheres.  As is 
the case with any bioartificial system with a linearly flowed media system, nutrient 
concentrations drop as media traverses over or through the matrix.  This most 
certainly would occur in a stacked sphere system.  The rate at which nutrient 
depletion would occur is directly related to the number of cells per unit volume that 
reside in the spheres.  A unique difference exists for systems that use spherical 
encapsulations.  Because the cells are contained within the hydrogel rather than 
loaded on the surface, cells are not subjected to the shear forces presented by the 
moving flow of media.  Because of this isolation from flow, encapsulated systems 
may utilize higher flow rates than those employed by superficially mounted cell 
systems.  Higher flow rates would allow for higher nutrient concentrations at all 
distances from the flow source as compared to traditional low flow of stagnant 
systems.  Figure 2-1 illustrates how uniform spherical encapsulations would stack 
and also demonstrates the aforementioned trend regarding concentration as a 
function of distance and flow rate. 
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Figure 2-1 
Three dimensional spherical encapsulation stack with nutrient concentration trend as 
a function of distance and media flow rate 
 
2.2.2 Encapsulation Design Parameters 
 
The first phase of this project focused on designing and manufacturing an 
encapsulation system.  The requirements for the encapsulation system were as 
follows: 
1. The system should be able to deliver spherical or other reasonably 
shaped geometry encapsulations containing cells in a permeable 
hydrogel.   
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2. The system should ensure viability of encapsulated cells.  The system 
should minimize cell exposure to adverse chemical, pressure, shear, 
thermal, and hypoxic environments.   
3. The system should be able to reproduce encapsulation size and viability 
under controlled conditions. 
 
2.2.3 Preliminary Designs 
 
The initial encapsulation system developed employed compressed nitrogen as 
the driver in an aerosol spray device consisting of a stainless steel spray head, 
syringe pump for delivery of the cell stock, and gas system to develop the aerosol 
spray.  This design was selected on the basis of low cost, operator safety, and ability 
to completely build the system in less than two weeks.  The aerosol system failed to 
deliver the desired spherical encapsulation and instead created large clumps of 
alginate with irregular geometries and diameters (or smallest measure in the case of 
irregular globular shapes) of greater than 800 microns.  As continuing studies 
illustrated the need for higher gas flow through the aerosol nozzle in order to achieve 
sub-millimeter diameter encapsulations, concern over pressures in the aerosol 
nozzle and shear forces through the narrow annulus of the nozzle ultimately resulted 
in abandonment of this system.  A parallel study undertaken in the David Gerber 
laboratories at UNC-CH sought to develop encapsulations by blowing air over the 
end of a small ejection port through which alginate cell stock was being pumped.  
This system produced encapsulates having few, if any, live cells.  This system is 
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believed to result in cell death due to pressure and shear force applied to the cells 
during processing. 
 
Figure 2-2 
Chandrasekaran/Gerber encapsulation system 
 
2.2.4 Electrostatic Encapsulation Device 
 
The final system explored for this project was ultimately an electrostatic 
encapsulation device employing high voltage direct current (DC) as the driving force 
for consistent encapsulation size control.  This system and its development are 
described in greater detail later in this work. 
 
2.2.5 Selection of alginate as a matrix encapsulator 
 
Sodium alginate was used to form the semi-permeable membrane on the 
exterior of the encapsulations.  Alginate polymerizes in the presence of plus two 
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charged cations and can therefore be added to aqueous cell stock to form hydrogel 
coatings following ejection into a receiving bath containing barium, calcium, or 
magnesium.  Similar techniques have been employed for several decades to 
encapsulate hepatocytes and islet cells isolations [3-5].  Alginate does not induce 
immune responses when used as an implant and can maintain structural and 
material properties for extended periods of time when used in culture [6-9].  
Furthermore, alginate encapsulations of hepatocytes have been shown to provide 
more efficient cytochrome P450 induction as compared to other culture systems due 
to the porous nature of the alginate allowing for the exchange of biologically active 
molecules into and out of the encapsulations [10]. 
 
2.2.6 Validation of Encapsulated Hepatocytes 
 
The second phase of this project encompassed characterizing encapsulations 
and monitoring the biological activity of encapsulated cells.  First, it was necessary to 
assess viability over a time course of up to twenty-eight days.  Fluorescent molecular 
probes were used to report cellular respiration in tandem with confocal microscopy 
to monitor cell viability for encapsulations cultured in two-dimensional (2D) plates.  
Confocal microscopy makes use of both laser and conventional light sources to 
produce images with resolutions below 10 microns through raster scanning to allow 
for optical thin-sectioning of samples with the need to fix or slice the specimen.   
Transmission electron microscopy (TEM) was used to observe the definition 
of ultra-structure of fixed cells in encapsulations.  TEM uses an electron beam 
directed at samples in a vacuum chamber which therefore requires significant 
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sample preparation and dehydration.  TEM imaging can allow for magnifications 
greater than 100,000x with an imaging resolution in the single nanometer range.   
Scanning electron microscopy (SEM) was used to image surface details of the 
alginate shell surrounding the hydrogel encapsulations.  SEM is similar to TEM in its 
use of an electron beam as the interrogation modality and the requirement of 
extensive sample preparation and dehydration to allow for specimens to be placed in 
the vacuum chamber of the instrument.  Unlike TEM, SEM does not require 
specimen slicing and instead makes use of conductive surface applications (typically 
gold, palladium, or mixed alloy) to the sample to allow for resolving of external 
surface details at magnifications in greater than 1,000x and imaging resolution in 
the single micron range. 
 
2.2.7 Metabolic Analysis of Media Streams 
 
Media collections were taken from bioreactors at 48 hour intervals.  These 
samples were studied using NMR spectroscopy to determine chemical constituents 
and concentrations.  Biofluid analysis has been a growing field of interest since 1983 
when Jeremy Nicholson published the first studies in the field of “metabonomics” 
[11].  The term “metabolomics” first appeared in the plant metabolic field in the early 
1980s.  Since that time, the majority of published research has been directed at plant 
metabolism.  In the later part of the 1990s, this focus began to shift to human and 
animal systems [12].  Early work in this field sought to exploit the power of NMR 
disaggregation of complex solutions when applied to blood, urine, and other 
biofluids.  This concept is expanded in the research contained herein to include 
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media samples taken from bioreactors serving as in vitro models for physiological 
systems.  In particular, the media samples represent non-hemoglobin proxies for 
blood in the bioreactors. 
Prior studies have analyzed media streams from systems containing porcine 
hepatocytes [13].  However, little conclusive metabolic insights were obtained.  The 
outlined goals above should serve as a guide in the development of a more robust 
method for observing metabolic activity over a broad range of indicators (glutamine, 
lactate, glucose, leucine, isoleucine, and others) resulting in a more complete picture 
of liver function using a 9.4 tesla magnet commonly found in laboratories 
throughout the research community.   
The described studies are intended as a demonstration of a method and do 
not attempt to fully characterize hepatocyte metabolic activity within the MCB 
environment.  Furthermore, total metabolic profiling by way of media studies cannot 
capture all metabolites as some charged species such as glutamate are unable to pass 
across the cell membrane and can therefore not be measured.  Suggested methods 
for observing these species are described in the future works section later in this 
dissertation. 
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2.3 Methods and Materials 
 
2.3.1 Cell Isolation Techniques 
2.3.1.1 Cell Isolation from Murine Liver 
 
Liver cells were isolated using a modification of the two-stage liver perfusion 
technique described by Seglen [14].  The hepatic progenitor cells were separated 
from mature hepatocytes using gravity separation and centrifugation. Full details of 
the isolation and characterization of the hepatic progenitor cells have been 
previously described [15].  
Mice where anesthetized using ketamine.  Following a reverse-T skin incision 
and transabdominal incision, the portal vein was catheterized using a 20 gauge 
angiocatheter.  The inferior vena cava was severed allowing for blood to flow out.  
The diaphragm was breached allowing access to the heart which was cut to terminate 
blood flow.  A buffered solution containing 0.5 mmol Ethylene glycol-bis-(2-
aminoethyl)-N,N,N',N'-tetraacetic acid (EGTA) in KRH (see chart below for solution 
reagents and concentrations) was perfused into the liver for five minutes followed by 
perfusion with a buffered solution containing collagenase for 8 to 12 minutes as 
determined by observation of the liver for capsule swelling at which time the second 
perfusion was terminated and the liver was removed from the specimen.  Liver cells 
were then collected and filtered using a buffered KRH solution containing 2 mmol 
CaCl2 and 6 grams/liter BSA.  Following filtering and centrifugation using the third 
buffer solution, cells were collected in low glucose Dulbecco’s modified Eagle 
medium (DMEM). 
22 
 
KRH Buffer Solution 
HEPES 25 mmol 
NaCl 115 mmol 
KCL 5 mmol 
KH2PO4 1 mmol 
 
2.3.1.2  Cell Isolation from Human Liver  
 
Adult human liver cells were isolated from donated cadaveric livers not 
suitable for orthotopic liver transplant.  The organs were obtained from federally 
designated organ procurement organizations with informed consent having been 
given by appropriate next of kin regarding use of tissues for research purposes.  
Livers were perfused through the portal vein and hepatic artery with an EGTA buffer 
containing Liberase (Roche, Switzerland), a purified collagenase.  Following 
digestion, organs were mechanically dissociated in a collection buffer maintained at 
37˚C.  The resultant cell stock was filtered and concentrated by low speed 
centrifugation. 
 
Figure 2-3 
Human liver cell isolation-perfusion (a), digestion (b-c), mechanical separation (d) 
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2.3.2 Encapsulation Device 
2.3.2.1 History 
 
The earliest documentation of an electrostatic bead device is found in US 
Patent 3,160,686 from 1964.  In this patent, Doyle describes a system which uses 
heat to liquefy low melting point polyethylenes, resins, or wax which when combined 
with other liquid agents may be propelled out of an annular port by electrostatic 
force.  The polyethylene, resin, or wax gels when making contact with a cooler 
receiving bath [16]. 
Such a design is suitable for the encapsulation of chemical and 
pharmaceutical agents which are not affected by the requisite heat of the process.  
Cells, however, are not suitable for use in this system due to cell death induced by 
the heat required to liquefy the gelling agent.  Moreover, the resultant 
encapsulations using polyethylene, resin, or wax would not provide sufficient 
diffusion needed for gas, nutrient, synthesis products, and wastes exchanged across 
the outer membrane of the encapsulation. 
Attention should be given to the application of the positive electrode in the 
Doyle design at the furthest point in the solution path from the ejection point.  This 
design in theory will maintain the entire conductive fluid body at a selected voltage 
above ground.  However, for small samples of viscous liquid potentially having air 
bubbles, such a design may allow for disruption of the electrostatic field.  A solution 
ensuring more consistent electrostatic field maintenance is described later. 
24 
2.3.2.2 Design Concept 
 
Spherical beads possessing a permeable external coating can be manufactured 
by use of a single tip electrostatic spraying system without the need for high 
temperatures as described by Doyle.  The system, which is comprised of a high 
voltage DC power supply, syringe pump for delivery of media, and a receiving bath 
that catalyzes bead gelling, can reproducibly cast beads with diameters of 100 μm to 
1mm ±8% at operating temperatures as low as 0˚C.  Bead size is determined by a 
combination of four factors: 
1. flow rate of the syringe pump,  
2. diameter of the ejection port (typically a 24 gauge 
angiocatheter),  
3. electric potential, and  
4. distance between the receiving bath and ejection port.   
Beads have successfully been cast using cell densities of 1x106 to 2x107 
cells/ml.  The typical bead gelling matrix is a 1:1 mix of low glucose D-MEM and 
aqueous alginate solution such that the final concentration of the gelling solution is 
1% alginate.  The gelling solution is combined with mature hepatocytes, hepatic 
progenitor cells, or a mixture containing multiple cell types.  Human and murine 
cells were used in the experiments described herein.  The solution containing cells is 
loaded into a syringe fitted with a 24 gauge angiocatheter modified to include the 
high voltage positive electrode.  A grounding electrode is placed into a 125 mmol 
calcium chloride (CaCl2) solution which serves as the receiving bath and catalyzes 
the polymerization of alginate in the gelling matrix as beads are cast into the bath.  
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Both the bath and gelling solution containing cells can be maintained at any 
temperature above their melting points allowing for cell degradation due to hypoxia 
to be minimized. 
 
 
 
Figure 2-4 
Electrostatic bead spray design       
 
 
Figure 2-5 
Doyle electrospray design, 1964 (U.S. 
Patent 3,160,686) 
 
Early trials revealed the need to control ejection port size, flow rate, distance 
from tip to receiving bath, and voltage in order to achieve spherical beads.  In tests 
with lower flow rates (0.25 ml/min to 0.5 ml/min), resultant beads consistently 
showed irregular geometry.  These encapsulations typically had a spherical body 
with a long, conical tail tapering away from the body of the bead.  Such tails were 
observed to line up in two-dimensional culture such that the tail of one bead would it 
between the spherical bodies of two adjacent beads preventing media flow through 
the matrix of encapsulations.  Increasing the flow rate to 0.714 ml/min resulted in 
spherical beads without tails.  Figures 2-6 and 2-7 illustrate the difference between 
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encapsulations having tails and those that do not.  Of particular interest are the 
inter-encapsulation channels present in Figure 2-7.  Without these channels, media 
would be unable to flow between the encapsulates. 
 
 
Figure 2-6   
Murine HPC encapsulations with irregular conical tails 
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Figure 2-7 
Mature hepatocyte encapsulations showing spherical geometry and inter-bead 
superfusion channels 
 
 
2.3.2.3 Safety Considerations 
 
Due to the high-voltage required to establish the electrostatic spray condition, 
a polycarbonate (Lexan®) case was designed and constructed to house the 
electrostatic spray equipment while providing reasonable protection to equipment 
operators.  The housing was designed to have two compartments.  The lower 
compartment was designed to hold a high-voltage power supply and magnetic stir-
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bar plate stacked vertically.   Particular attention was given to isolating the high-
voltage supply from liquids used in the experiment.  The upper compartment was 
designed to support stands for maintaining appropriate distances and alignments of 
the electrostatic spray ejection port and receiving bath.  The delivery pump for 
gelling stock delivery was located in this area upper area of the cage to minimize flow 
distances from pump to ejection port.  The initial design for the cage included a 
frontal plate to prevent users from incurring electric shock by accidental 
introduction of body parts into a line of continuity between the high-voltage DC 
source and any reasonable ground in the room.  Early attempts to use the 
electrostatic device proved challenging with the frontal plate blocking the controls of 
the pump, stir plate, and power supply.  Because of these complications with 
addressing the control systems during encapsulations, the cage was ultimately 
rotated 180˚ allowing for free access to all controls.  In response to this change, the 
“one-hand-in-a-pocket” rule was employed to avoid provision of electrical paths that 
could cause shock, electric burns, or other serious injuries [17].  Additionally, safety 
measures recommended by the National Institute for Occupational Safety and 
Health were undertaken such that no encapsulations were performed by an 
individual operator [18].   
While the electrostatic process by definition occurs at zero amperage, the high 
voltage delivered by the Spellman power supply could register sub-milliamp currents 
when provided with appropriate grounding.  Such currents in the operational voltage 
range would be able to induce ventricular fibrillation [17, 19].  In Figures 2-8 and 2-
9, the high voltage source and stir plate are isolated below the operational deck of the 
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safety cage away from the liquid gelling stock and aqueous receiving bath as an 
additional safety measure.   
 
Figure 2-8 
Schematic for Lexan safety case 
Figure 2-9 
Open front safety cage setup
 
 
To achieve the high-voltage, electrostatic field required to drive the 
electrospray device, a high-voltage DC source (Spellman model RHR30PF30, 
Hauppauge, NY) was used with voltages in the range of 3.8 to 6 kilovolt (KV).  The 
positive electrode was established 2 cm above the ejection port by piercing the 
angiocatheter with a 22 gauge needle connected to the Spellman high-voltage source.  
This ensured that the electrostatic field was maintained throughout an experiment 
without disruption caused by small air bubbles that may exist in the fluid body 
causing loss of continuity.  This design enhancement was undertaken after initial 
attempts to use the Doyle design for electrode placement resulted in formation of 
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long strands of alginate extruded into the CaCl2 bath under zero voltage potential 
due to continuity disruption.  
 
2.3.2.4 Grounding 
 
The ground electrode for the high-voltage source was attached to benchtop 
plumbing by copper wire and a one inch hose clamp.  This method was employed as 
conventional grounding plugs in 120 volt laboratory wiring may be unsuitable in for 
grounding voltages greater than specified usage.  This plumbing based grounding 
scheme was recommended by the Spellman Company, manufacturers of the high 
voltage source used in these studies. 
 
2.3.2.5 Liquid Delivery 
 
Media stocks containing cells, alginate, and/or Matrigel were delivered 
through the encapsulation system by syringe pump.  Typically, a 1 or 3 cc syringe was 
loaded into a syringe pump (Braintree Scientific BS-8000, Braintree, MA) arranged 
in the z-axis such that the expressed solution would exit the ejection port at the 
bottom of the pump and fall orthogonally onto the surface of a 150 ml receiving bath 
of 125 mmol CaCl2 in a 250 ml Pyrex beaker.  Pump flow rates were set in the range 
of 0.75 to 1.5 ml/min.  The pump was mounted on an insulated riser to provide 
electrical isolation from possible spills on the operational deck of the safety cage.  
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This also minimized the null volume required to pump gelling solution from the 
pump to the spray nozzle resulting in more efficient encapsulation studies. 
 
2.3.2.6 Ejection Ports 
 
Initially, a variety of angle tipped needles were employed as ejection ports for 
the cell stock solutions delivered from the syringe pump.  Uniformity in diameter of 
the tip was an important consideration which was easily satisfied by metal needles.  
Metal needles also offer excellent conductivity when an electrode is clamped to the 
exterior of the tip.  Unfortunately, the angled tip failed to produce regular spherical 
encapsulations.  Angle tipped needles were therefore abandoned in favor of flush cut 
angiocatheters.  Preliminary trial and error led to the use of 24 gauge angiocatheters 
as the standard ejection port for all experiments.  This selection was made based on 
the diameter of encapsulations which could be achieved at voltages that did not 
produce arcing.  Arcing voltages were found above 6 kV.  Using a 24 gauge 
angiocatheter, spherical encapsulations with diameters below 500 µm could be easily 
reproduced at voltages in the 4 to 5 kV range with the distance between the ejection 
port and the CaCl2 bath in the range of 2.0 to 3.0 centimeters (cm).  
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2.3.3 Culture Environments 
2.3.3.1 Multi-Coaxial Bioreactor 
 
The Multicoaxial Bioreactor (MCB) is made of biocompatible materials 
engineered to proprietary specifications under design specifications provided by Jeff 
Macdonald [20].  All bioreactors used in studies described in this thesis were 
constructed onsite at ADMET Technologies, Inc. (Research Triangle Park, NC) from 
parts fabricated at the UNC Physics Instrument Shop (Chapel Hill, NC).    
Media In/Out Center Compartment
Media In/Out
Gas In/Out
Cells or Encapsulations In
 
Figure 2-10 
Bioreactor loading and flow diagram 
 
Each MCB was primed and sterilized with ethanol under continuous flow 
provided by pump feed for twenty-four hours.  Each MCB was next washed with cell 
culture media to remove ethanol from the entire system.  After the completed MCB is 
flushed and activated with cell culture media, the MCB is inoculated with a human 
liver cell preparation (UMIX®) shown to contain hepatic stem/progenitor cells as 
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well as non parenchymal cells.  Cells were inoculated in either in a mixed gel 
composed of collagen and Matrigel or in encapsulations containing 1% alginate, 
Matrigel, and DMEM.  The cells or encapsulates were sandwiched between two 
media compartments.  Multiple MCBs were set up in a single incubator for facile 
media sampling over regular time intervals.  
 
Figure 2-11 
Multiple MCBs with gassing and media pumps 
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2.3.3.2 MCB Media Formulation 
 
All bioreactors were circulated with a modified DMEM solution (Gibco, 
Carlsbad, California) having no phenol red and no glutamine.  To this solution, 
additional ingredients listed in the table below were added. 
DMEM Solution Additional Ingredients 
Pen/Strep Antibiotic 10 ml/L 
Spite 10 ml/L 
Albumax 2 g/L 
HEPES 5.958 g/L 
Niacinamide 600 mg/L 
Beta mercapto 1 ml/L 
2-13C/15N glycine 0.4 mmol 
15N Glutamine 0.5 mmol 
 
2.3.3.3 Two-Dimensional Plating 
 
Three-dimensional encapsulations where incubated in two-dimensional 
plates allowing for a single layer of encapsulations to rest submerged in media.  
These plates allowed for easy access to encapsulations for microscopy studies.  The 
alginate beads were suspended in DMEM plus 10% fetal bovine serum (FBS), 20 
mmol HEPES, 10 mmol nicotinamide, 1 mmol ascorbic acid 2-phosphate, 1 µM 
dexamethasone, 0.5 mg/L ITS (insulin-transferrin-selenium) solution, 30 mg/L 
proline, 100 mg/L antibiotic solution, and 10 ng/ml epidermal growth factor (EGF) 
in 24- well plates or 35 mm covered culture plates at a density of 1x106  to 20x107  
cells/ml of encapsulation stock.  The plates were kept in a 5% CO2/95% room air 
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incubator at 37°C.  The media was changed every 3 days, and the supernatant was 
collected for analysis.  As a control, hepatic progenitors were cultured on 24-well 
dishes at a cellular density of 5x105 cells/well under the same culture conditions. 
 
2.3.4 Sample Collection Methods 
2.3.4.1  Media Collections 
 
Media was removed from bioreactors every 48 hours and replaced with fresh 
media.  Prior to media exchange, a sample of media was extracted from the 
bioreactor system using a syringe fitted with an 18 gauge needle utilizing aseptic 
technique.  Media samples were maintained at -80˚C until completion of individual 
bioreactor studies.  All samples from any single bioreactor experiment were thawed 
simultaneously and prepared in accordance with the metabolomic procedure 
described later in this work allowing for batch serial analysis.  Control bioreactors 
possessing acellular encapsulations or gel were maintained under the same 
conditions and media change regimen as those containing hepatocytes in 
encapsulations or gel. 
 
2.3.4.2 Matrix-Based Cell Collection 
 
Samples contained in bioreactors were fixed for microtomy by injecting 
optimal cutting temperature (OCT) glycol/resin solution into the inner and outer 
chambers of the bioreactors before freezing.  OCT was not introduced into the 
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central compartment of the bioreactor due to concerns that the viscous liquid might 
compress the encapsulations or other cell-bearing matrices.  The bioreactors were 
then thin sectioned using a cryostat.  Thin sections were placed onto slides for 
imaging with confocal microscopy. 
 
2.3.4.3 Alginate Bead Disintegration by Sodium Citrate Wash 
 
For studies that removed cells from encapsulations, a 75 mM sodium citrate 
solution was used to disintegrate the alginate encapsulation [21].  Citrate is a useful 
chelating ligand for divalent cations such as Ca+2 [22].  The chelation of calcium 
initiates the disintegration of the polymerized alginate.  Encapsulations were placed 
in a 50 ml tube with the citrate wash and agitated manually until encapsulations 
were observed to disappear.  Cells were pelleted using low speed centrifugation and 
resuspended in culture media. 
 
2.3.5 Microscopy Techniques 
2.3.5.1 Light Microscopy 
 
The beads were visualized under a Zeiss Axiocarvert 100 (Carl Zeiss Inc., 
Thornwood, NY) inverted transmission microscope to ensure that 2D plates were not 
contaminated during time series studies.  Inverted light microscopy was also used to 
study cell distribution inside the beads and also to determine bead size 
measurements.  
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2.3.5.2 Confocal Microscopy 
 
Murine and human encapsulated samples were treated with 90 nanomolar 
(nM) solutions of MitoTracker® Red (Molecular Probes, M7512, Eugene, OR), a 
fluoroprobe that emits light when in the mitochondria of respiring cells.  Preliminary 
studies suggested that incubations of 15 to 30 minutes in the fluoroprobe solution 
did not yield even staining within the encapsulations.  Therefore, the fluoroprobe 
was loaded at a concentration of 90 nM directly in the liquid alginate/cell 
encapsulation stock prior to electrostatic encapsulation.   
Encapsulations were visualized using a Zeiss LSM-510 or a Zeiss LSM-210 
(Carl Zeiss Inc., Thornwood, NY) inverted confocal microscope to assess cellular 
viability distribution with in the three-dimensional structure of the bead.  Beads 
were observed in DMEM in 35 mm glass bottom dishes. 
 
2.3.5.3 Electron Microscopy Methods 
2.3.5.3.1 Transmission Electron Microscopy (TEM) 
 
Time series bead samples were fixed in a 2.5% glutaraldehyde solution with 
0.2M sodium cacodylate with 0.01M CaCl2 and stored at 4˚C until all were batch 
processed.  Samples were treated with osmium tetroxide for 1 hour.  Samples were 
dehydrated using a four-concentration process including 30%, 50%, 75%, and 100% 
ethanol immersion for 5 minute periods with three washes being performed at the 
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100% ethanol step.  Samples were split into equal portions for final TEM and SEM 
preparation. 
Transmission electron microscopy samples were then washed in propylene 
oxide followed by immersion in a 1:1 solution containing propylene oxide and epoxy 
resin.  The TEM samples were embedded next in 100% epoxy and sectioned using 
ultra-microtomy techniques [23].  TEM Samples were observed using the LEO EM 
910 (LEO Electron Microscopy, Thornwood, NY). 
 
2.3.5.3.2  Scanning Electron Microscopy (SEM) 
 
Following dehydration gradient ethanol series washing, critical point drying 
was applied to the scanning electron microscopy samples using high pressure carbon 
dioxide.  SEM samples were then sputter coated with gold/palladium alloy to 
increase sample conductivity [23].  SEM samples were observed using the 
Cambridge S200 (Carl Zeiss Inc., Thornwood, NY). 
 
2.3.5.4 NMR Techniques 
2.3.5.4.1 Sample Preparation 
 
Media samples were combined 1:1 with a phosphate buffered deuterium oxide 
solution containing sodium formate for use as a concentration reference.   As all 
samples were buffered media solutions, there was no need to titrate samples to 
correct for pH.  
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2.3.5.4.2 Reference Selection 
 
The use of 3-(trimethylsily)propionic-2,2,3,3-d4 acid sodium salt (TSP) as a 
reference for chemical shift due to the fact that the chemical shift for TSP is a singlet 
at 0 parts per million (ppm).  TSP also allows for simple algebraic determination of 
concentration for all peaks present in the solution by proton weighted normalization 
of peak areas compared to the area of the TSP peak.  TSP, however, has been 
reported to bind non-specifically with some proteins reducing the peak signal and 
allowing for errors to be made in the determination of concentration of constituents 
in samples containing protein [24].  A solution of equal weighted TSP and sodium 
formate peaks was prepared.  Spectra of the two reference solutions alone and in 
conjunction with media revealed that the TSP was likely binding to albumin or some 
other constituent of the media solution causing systemic errors in calculation of 
concentration.  Because this error was non-specific and had a relatively large 
standard deviation, sodium formate was determined to be the better reference for 
the NMR studies conducted from that time forward. 
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Figure 2-12 
Comparison of spectra with TSP and formate references 
 
2.3.5.4.3 Pulse Sequence 
 
The metabolomics assay was performed on a Varian 400 megahertz (MHz) 
magnet.  The NOESY (Nuclear Overhauser Effect Spectroscopy) pulse sequence was 
used with 32 transients per sample and a D1 time of 10 seconds.  The NOESY pulse 
sequence was selected for its ability to produce narrow peak widths and excellent 
solvent (H2O) suppression.  A graphical interpretation of the pulse sequence can be 
found in Figure 2-13.  Transmitter power level was maintained at 56 for all samples. 
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100.0u                       100.0u 43.5s                                   10.0u  0.0u                     10.0u
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2.0m                               2.0m
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Figure 2-13 
NOESY pulse sequence 
 
2.3.5.5 Biolyzer Techniques 
 
Media samples from experimental and control bioreactors as well as 2D 
control plates were analyzed using the Kodak Biolyzer Rapid Analysis System 
(Rochester, NY).  All samples were frozen at -80˚C prior to analysis.  All samples 
were processed in accordance with Kodak standard protocols.
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2.4 Results 
2.4.1 Microscopy Data 
2.4.1.1 Light Microscopy 
 
Light microscopy was employed to determine whether or not encapsulations 
had uniform spherical geometry.  Early experiments demonstrated the need to adjust 
both voltage and pump flow rate to produce spherical beads.  Through the use of 35 
mm culture dishes with a small volume of media, encapsulations would settle to the 
bottom of the dish allowing for any perturbation in geometry to be observed as the 
encapsulations would settle to positions having the lowest energy which would 
routinely result in the exposure of irregular protruding features when viewed or 
digitally photographed using light microscopy.   
 
2.4.1.2 Electron Microscopy 
2.4.1.2.1 Transmission Electron Microscopy 
 
Encapsulated and free cell samples were prepared as described earlier and 
imaged using a LEO 910 EM Transmission Electron Microscope.  Many of the cells 
imaged in thin sections from encapsulations demonstrated grainy, poorly-defined 
ultra-structure suggestive of necrosis.  This finding suggests that either the 
encapsulated cells could not survive either the initial encapsulation technique or 
subsequent fixation process.  However, cells demonstrating more definitive 
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mitochondria were found representing less than 10% of the cells observed in thin 
sections of encapsulations. 
 
Figure 2-14 
TEM of encapsulated cell showing mitochondria 
 
Concern regarding cell death due to the encapsulation process was dismissed 
following the positive results of both confocal microscopy and NMR metabolic 
validation described later in this work.  These findings suggested that the necrosis 
may be due to the fixation process being slowed by the encapsulation matrix 
allowing for cells with the encapsulation to succumb to necrotic death.  A method 
was developed using sodium citrate to disrupt the encapsulations to free the cells.  
Mitochondria 
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This allowed for the free cells to be taken from an encapsulation and fixed.  These 
freed cells were then compared to control cells taken from same study but not 
subjected to either the encapsulation technique or the sodium citrate encapsulation 
reduction.  TEM of the control cells found well-defined ultra-structure with distinct 
intra-cellular features and crisp plasma membrane (Figure 2-15). 
 
Figure 2-15 
TEM of control cell (non-encapsulated) 
 
Plasma membrane 
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2.4.1.2.2 Scanning Electron Microscopy 
 
SEM allowed for the preparation of entire encapsulations without the need for 
thin sectioning.  This allows the advantage of interrogating the entire external 
surface of an encapsulation.  The findings from this line of study demonstrated that 
the exterior of observed encapsulations had a dramatic topographical surface with 
alternating peaks and valleys running along nearly parallel longitudes of the 
encapsulation. 
 
Figure 2-16 
SEM of alginate encapsulation observed at 575x magnification 
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This observation was in stark contrast to the expectation of a smooth exterior 
to the encapsulations.  This finding was suggestive of systemic dehydration resulting 
from sample processing with ethanol gradient staged dehydration.  However, such 
dehydration which would result in the shrinking and wrinkling of encapsulation 
surfaces might also occur at earlier steps in the process.  Review of other images 
uncovered one sample that did show signs of possible superficial wrinkling.  A series 
of encapsulations had been observed confocally that show similar surface 
characteristics.  Due to the thin section viewing associated with confocal microscopy, 
the surface topography is considerably less apparent and was initially dismissed as a 
feature associated with a flaw in the angiocatheter used during the encapsulation 
process. 
 
Figure 2-17 
Confocal slice of encapsulation showing possible dehydration deformations of the 
exterior surface 
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It is important to note that the cells contained in the encapsulations of Figure 
2-17 register as alive by fluorescence observance.  This prompted an intensive 
interest in ensuring that all processing occurred in isotonic solutions to diminish the 
opportunity for variations in salt concentrations to damage encapsulations and 
contained cells. 
 
2.4.1.3 Confocal Microscopy 
 
Encapsulations were visualized using a Zeiss LSM-510 inverted confocal 
microscope to assess cellular viability distribution with in the three-dimensional 
structure of the bead.  For Figure 2-18 and Figure 2-19, MitoTracker® Red as loaded 
into the liquid encapsulation stock at a concentration of 90 nM.  Encapsulations 
were observed in DMEM in 35 mm glass bottom dishes. 
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Figure 2-18 
Confocal images of human UMIX® in alginate/Matrigel bead with MitoTracker® Red 
taken at 24 hours post encapsulation 
 
Figure 2-18 illustrates confocal slices of an encapsulation containing human 
UMIX®.  Because the fluorescence channel is captured confocally while the 
transmitted light is captured for the full sample thickness, the appearance of small 
cellular bodies that do not fluoresce may lead to the erroneous conclusion that the 
majority of cells shown in the image are dead.  This, however, is not the case as only 
a small thickness of the encapsulation is registered on the fluorescence channel and 
being combined with non-fluorescing images both above and below the confocal 
plane.  The intended effect of combining the two images is to illustrate the size of the 
bead, the viable cells within a narrow cross-section, and the obstructions below the 
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focal layer (inverted microscope) which lay between the fluorescing live cells and the 
microscope detector.  This obstruction issue can be observed by comparing the four 
images and observing the density of the fluorescent signal as a function of depth.  In 
the first image, taken just at the base of the encapsulation nearest the objective, the 
fluorescence is contained in the center of the bead. 
Similar results were obtained with murine HPC encapsulations examined with 
confocal microscopy.  Figure 2-19 shows a z-axis stack of confocal images 
penetrating into a single encapsulation.  The top left block is the most superficial 
while the image at the lower right represents a confocal slice 90 µm into the 
encapsulation.  
 
Figure 2-19 
Serial confocal slices of a murine HPC encapsulation stained with MitoTracker® Red 
 
Cross-sectioned bioreactors containing encapsulations and cells in mixed 
matrix were viewed using confocal microscopy as well.  The bioreactors were 
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sacrificed 31 days after inoculation after being stained with live/dead fluoroprobe 
stains.  Images consistently show encapsulations in the inoculated chamber adjacent 
one of the chamber walls or pressed against other encapsulations.  In nearly every 
case, the spherical geometry of the encapsulations was distorted.  Figure 2-20 shows 
the geometric perturbation but also shows increased fluorescence at the interface 
between two encapsulations pushed together.  This is suggestive of cellular mobility 
within the encapsulation leading to cell aggregation. 
 
Figure 2-20 
Confocal image of thin-sectioned bioreactor containing encapsulations at day 30 post 
inoculation (10 million cell/ml H0540) 
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2.4.2 NMR Data 
2.4.2.1 Concerns regarding ethanol 
 
Early in the NMR analysis process, concern arose surrounding the presence of 
a triplet centered at 1.18 ppm which was determined to be ethanol in the collected 
media samples.  Initial findings from the TMS referenced studies showed erratic 
concentrations.  It was originally thought that the switch to sodium formate 
referencing would reveal a more consistent trend.  For the control bioreactor 
containing mixed gel (alginate and Matrigel) the formate referenced spectra show a 
decreasing concentration trend as a function of time. 
 
Figure 2-21 
Transformed NMR FIDs for bioreactor control samples with time progressing from 
bottom to top 
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Figure 2-22 
Ethanol concentration as a function of study day for control bioreactor (H0540 Study) 
 
The diminishing trend shown in Figure 2-22 suggests that the presence of 
ethanol is the result of pre-study sterilization and bioreactor wetting both of which 
employ ethanol to prepare the bioreactor prior to inoculation with gel matrix or 
encapsulations. 
This trend was observed in bioreactors containing cells as well.  However, at 
certain time points, the ethanol concentration increased abruptly as shown in the red 
circled data point in Figure 2-23.  This was originally thought to be an indication of 
biological contamination by bacteria, yeast, or fungus.  The concentration profile for 
ethanol was not consistent with contamination in that the ethanol level would drop 
in the sample taken 48 hours later.  This would suggest an analytical error or 
calibration error.  Other chemical concentrations including glucose and acetate were 
monitored for use as measures of NMR stability due to the belief that these 
compounds would demonstrate reproducible concentrations over time points in the 
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study once the bioreactor had stabilized.  As predicted, the concentrations for these 
compounds remained nearly linear supporting the stability of the method while also 
challenging the notion that a biological contaminant was present.   
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Figure 2-23 
Ethanol concentration as a function of study day for mixed matrix experimental 
bioreactor (H0540 Study) 
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Figure 2-24 
Ethanol concentration as a function of study day for encapsulation experimental 
bioreactor (H0540 Study) 
 
A review of lab procedure related to collection of bioreactor media revealed 
the practice of swabbing a tubing port with ethanol prior to drawing samples with a 
syringe fitted with an 18 gauge needle.  Owing to the large area of the port septum 
that an 18 gauge needle would cross, it is believed that the erratic behavior of the 
ethanol concentration is the direct result of contamination of the needle used to 
draw samples as it passed through the port septum.  Such a finding is a clear 
demonstration of the sensitivity of NMR for low concentrations as well as a reminder 
that technicians must take care to use lab practices that minimize technique-induced 
errors to measurements. 
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2.4.2.2 Glutamine Metabolism 
 
NMR results show that for both the mixed matrix bioreactor and 
encapsulation bioreactor glutamine was metabolized to completion following day 
five with media changes performed at 48 hour intervals.  Figure 2-25 shows the 
results for glutamine metabolism as determined by NOESY pulse sequence NMR 
spectroscopy.  Of particular note is the abrupt drop in glutamine in the control series 
following day 15.  This is most likely due to the addition of 10 mmol ammonia to the 
media circulation at day 16 as a test to determine cellular BUN and urea response. 
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Figure 2-25 
Glutamine metabolism as a function of study day for 10 million cells/ml (H0540) 
 
56 
2.4.2.3 Acetate Metabolism 
 
The data for acetate concentrations as a function of time as determined by 
NMR measurement are shown in Figure 2-26. 
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Figure 2-26 
Acetate concentration as a function of time 
 
2.4.2.4 Lactate Metabolism 
 
The data for lactate concentrations as a function of time as determined by 
NMR measurement are shown in Figure 2-27. 
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Figure 2-27 
Lactate concentration as a function of time 
 
2.4.3 Biolyzer Data 
2.4.3.1 Bun/Urea Concentration 
 
Biolyzer analysis of BUN/Urea concentrations of bioreactor media streams 
comparing encapsulations and cells loaded directly into Matrigel are shown in Figure 
2-28.  The results indicate that the BUN/Urea concentration observed in the 
encapsulations having 10 million cells/ml are consistently less than the 
concentrations for both 7 and 10 million cells/ml directly loaded in Matrigel 
bioreactors.  The abrupt drop in concentration beyond day 15 is the result of the 
bioreactors being spiked with 10 mmol ammonia on day 16 of incubation. 
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Figure 2-28 
Time series BUN/Urea concentration for 7 and 10 million cells/ml gels, 10 million cells 
per ml, and controls 
 
2.4.3.2 LDH Concentrations as a function of time 
 
Biolyzer analysis of LDH concentrations of bioreactor media streams 
comparing encapsulations and cells loaded directly into Matrigel are shown in Figure 
2-29.  Of particular note is the diminishing concentration in all experimental 
bioreactors during the first five days. 
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Figure 2-29 
Time series LDH concentration for 7 and 10 million cells/ml gels, 10 million cells per 
ml, and controls 
 
 
2.4.4 Cryopreservation Storage Tests 
 
The practical utility of encapsulations will be limited by the ability to store 
and transport the encapsulations with relative ease.  With this in mind, experiments 
were undertaken to explore methods for cryopreservation.  An important 
consideration with any aqueous filled body is the expansion of water upon transition 
to the solid phase.  An optimistic working hypothesis regarding this phenomenon 
was that the alginate gel would sufficiently expand to maintain spherical structure 
when frozen.  Tests to determine geometric stability following conventional 0˚C 
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freezing and -80˚C freezing with thawing resulted in destruction to the integrity of 
the alginate encapsulations. 
 
Figure 2-30 
Post-thaw 10x light microscopy image of -80˚C frozen encapsulations 
 
2.4.5 Analysis of Metabolic Findings 
 
The LDH findings illustrate that the initial isolation and/or encapsulation 
causes disruption of hepatocyte function and cellular damage.  Within five days, the 
LDH level lowers illustrating that cells have stabilized.  Under the stress of isolation 
and encapsulation, it is likely for the cells to experience temporal hypoxia resulting 
in anaerobic glycolysis.  This is supported with an inspection of the NMR time series 
analysis of lactate in which the concentration for experimental samples is elevated 
for the first five days of study then drops to levels consistent with the acellular 
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control.  Similarly, the slow return of glutamine metabolism during the first five days 
after encapsulation supports anaerobic metabolism consistent with the other 
findings.  Figure 2-31 illustrates the release of LDH due to cell death and the 
anaerobic metabolism leading to lactate.  
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Figure 2-31 
LDH release associated with cell death and anaerobic metabolism 
 
The confocal results of sectioned bioreactors and of encapsulations incubated 
for up to thirty days show live cells as indicated by MitoTracker® Red.  This is further 
supported by the consumption of glutamine to exhaustion in the bioreactor media 
analysis by NMR.  The glutamine metabolism indicates that aerobic metabolism in 
the mitochondria is feeding into the TCA cycle as glyconeogenesis and 
gluconeogenesis are upregulated as illustrated in Figure 2-32.  Similarly, the increase 
in BUN/urea levels in experimental bioreactors beyond day five indicates a return to 
protein metabolism.  
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Figure 2-32 
Glutamine metabolism under aerobic conditions 
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3 High Through-put NMR Analysis of Culture Media 
for Bioreactors1 
3.1 Abstract 
 
This chapter describes a high through-put (HTP) NMR method for analysis of 
components in culture media.  The spin-lattice relaxation (T1) values and 
concentrations were measured for 19 components in culture media and two internal 
referencing agents, formate and 3-(trimethylsily)propionic-2,2,3,3-d4 acid sodium 
salt (TSP), in pure and two-day conditioned culture media from a multi-coaxial 
human bioartificial liver (BAL).  Pure media had the highest overall T1 values, the 
longest T1 being formate at 8.3s, while TSP had the most significant change in T1 
with addition of albumin, likely due to protein binding. Using a 400 MHz NMR 
spectrometer the 1H NMR spectral signal-to-noise ratio for 0.16 mM alanine in 
media is 21 and obtained in 14 minutes , resulting in HTP automated analysis.  To 
demonstrate the HTP 1H NMR method, multicoaxial BALs were batch cultured (i.e., 
                                                   
1 This chapter is adapted from a publication entitled High Through-put NMR Analysis of Culture 
Media for Quality Assurance and Metabolomics for Tissue Engineering by Christopher Seagle, 
Megan A. Christie, Jason Winnike, Randall McClelland, John Ludlow, Thomas O’Connell, and 
Jeffrey M. Macdonald.  At the time of publication of this dissertation, the article had not yet been 
submitted to any peer-review journal. 
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media changed every other day) for 15 days after inoculation with human liver cells 
in Matrigel™:collagen type 1 gels and compared to 2D gel cultures.  The results 
showed that glutamine consumption was higher by day 8 in the BAL as compared to 
2D culture, while lactate production was lower through the 15 day culture period.  
Alanine was the primary amino acids produced during the culture period and it 
tracked lactate or urea production.  Glucose and pyruvate consumption were similar 
between the BAL and 2D cultures.  The unbiased NMR analysis permits quality 
assurance of unknown potential contaminants, and a case in point is residual ethanol 
resulting from the bioreactor membrane ‘wetting’ procedure.  The combination of 
robotic NMR sample changer and group integration of 1H NMR spectra results in 14 
minutes per sample using an extremely common 400 MHz NMR spectrometer.  A 
biochemical scheme is presented to translate bioreactor metabolomic footprint 
results into either bioreactor operational parameters, such as media nutrient (i.e. 
oxygen, glutamine,…) concentration, or quality assurance issues. 
 
3.2 Introduction  
 
High-throughput (HTP) NMR spectroscopic analysis of media provides an 
unbiased determination of biochemical concentrations permitting culture protocol 
modifications to be rapidly implemented for optimizing culture conditions [1-3].  In 
combination with bioinformatic tools [4] this analytical method provides robust 
characterization of phenotypes for tissue engineering.  Unlike analytical modalities, 
NMR spectroscopy does not require extensive sample preparation and is innately 
quantitative resulting in unbiased analysis.  This makes NMR spectroscopy one of 
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the most powerful analytical techniques available for quality assurance which is 
particularly important for tissue engineering due to the multitude of operational 
parameters, and potential for human error and contamination.  This is particularly 
true for engineered bioartificial liver (BAL), where clinical liver assays are used to 
characterize degrees of liver function and differentiation.  There is a need for a more 
robust method of reporting the hepatic phenotype of BALs [5].  Metabolomic 
analysis fills this requirement [6]. 
The state-of-the-art method to quantify concentrations in media is HPLC and 
mass spectroscopy [7-9].  Media component analysis by 1H NMR spectroscopy has 
been attempted since the 1980s [2, 3, 10-12] but has never been widely-accepted, 
likely because the NMR results were less sensitive than HPLC, and more 
importantly, the unbiased nature of NMR was not appreciated.  Now with high field 
NMR spectrometers more common and development of multivariate statistics for 
metabolomics [13, 14] the unbiased strength of NMR makes it perhaps one of the 
most powerful techniques for phenotyping tissues especially 3D tissue constructs in 
tissue engineering.  Although direct analysis of the tissue can be performed, the 
bioreactor dimensions must conform to existing NMR hardware [15] or the NMR 
hardware must be built around the bioreactor [16], in a similar fashion as the 
NMR/MRI analysis of a human tissues.  Media analysis serves a similar function as 
monitoring the central compartment, or blood, of a human.  The distinctions 
between the compliment of metabolites within the cells - “the fingerprint” - and from 
those outside the cells - “the footprint” - are given by two different metabolic profiles 
[17].  The fingerprint and footprint is tissue specific and depends on the degree of 
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metabolic differentiation, resulting from the number and capacity of transporters, 
and signaling and metabolic pathways. 
The same problems associated with  NMR spectroscopic analysis of serum 
apply to culture media, including differences in spin-lattice relaxation (T1) values due 
to noncovalent protein binding resulting in inaccurate determination of 
concentrations [18].  The spin-lattice relaxation (T1) values have never been reported 
for components in culture media and are necessary to insure accuracy of the NMR-
derived concentrations [3].  Therefore, a HTP NMR method has been optimized 
whereby T1 values of media components calculated.  In addition the sample 
preparation conditions were optimized, and the spectral parameter identified to 
obtain 1H NMR spectra of media within 10 minutes with bulk spectral integration to 
rapidly convert peak areas to metabolite concentrations.  To demonstrate the 
application of the HTP NMR method to optimizing tissue culture protocol, we apply 
the method to development of a commercially-available bioartificial liver [19, 20].  
 
3.3 Methods 
 
NMR supplies were purchased from multiple vendors.  The 5 mm tubes, 
deuterium oxide, sodium formate, and 3-(trimethylsily)propionic-2,2,3,3-d4 acid 
were purchased from Sigma Chemical company (St Louis, MO), Cambridge Isotope 
Laboratories, (Andover, MA), Alfa Aesar (Ward Hill, MA), and Isotec Inc. 
(Miamisburg, OH), respectively.  Bioreactor end pieces were machined from 
polypropylene tube (1 in. diameter) and assembled as previously described [16, 19].  
Bioreactor life support units have been described previously [8].  Matrix supporting 
69 
the cells was made up of 1:1 (vol:vol) collagen type I and Matrigel™ from Inamed 
Biomaterials Inc. (Irvine, CA) and Becton Dickenson Inc. (BD, Franklin Lakes, NJ). 
 
3.3.1 BAL Inoculation, Media, and Media Collection  
 
The human BAL studies were performed at the ADMET Technologies Inc. 
(Research Triangle Park, NC) laboratory using their patented multicoaxial bioreactor 
[21] and using their primary human liver cells, UMIX, as described on their webpage 
(http://www.admettechnologies.com/).  Liver cells were mixed with a 1:1 collagen-
to- Matrigel™ mixture (vol:vol) and inoculated at a density of 107 cells/ml.  The 
media was a hormonally-defined recipe, Kubotas media [22], using the  Dulbecco's 
Modification of Eagle's Medium as the basal media (Mediatech 17-205-CV, Herndon, 
VA).  The media was changed in batch mode the day after inoculation followed by 
every two days, and placed in a -80ºC freezer until analysis, at which point it was 
thawed.  Flow rates through the BAL were 5 ml/min, and oxygen concentration was 
95% as described by McClelland and Coger  [23]. 
 
3.3.2 2D Culture  
 
Hepatocytes obtained from a single human liver were cultured immediately 
following isolation using the same cell and matrix mix as described in the BAL 
Inoculation and Media Collection methods section was plated on a pre-coated 6-well 
Collagen Type I plate from BD  (Franklin Lakes, NJ) at a 1.25ml volume per well, or 
12.5 million cells.  The cell and matrix solution was placed in a 37°C humidified 
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incubator with 5% CO2 for 1 hour to gel properly.  Media was then added to the 
culture at a volume of 2 ml per well.  Media was changed 24 hours after plating and 
every other day thereafter for all cultures.   
 
3.3.3 3D Culture of UMIX 
 
Figure 3-1 shows the multicoaxial bioreactor with all of the ports identified 
(left), and the bioreactor incorporated into the life support system (right).  The 
bioreactor is placed inside an incubator with the reservoir, pump, and various 
tubings.  The gas is composed of oxygen:carbon dioxide (95:5), and the gas line is 
inserted through the side of the incubator and attached directly to the bioreactor and 
dead-ending at the reservoir, which vents through a 0.2 μm pore polypropylene air 
filter.  The temperature of the incubator is 37° C. 
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Figure 3-1 
Bioreactor design and flow loops 
 
3.3.4 Optimization of NMR Pulse Sequence for Quantification 
of Media Components 
 
Four pulse sequences were compared for maximum signal-to-noise ratio, the 
1H one-pulse with presaturation using a 45° flip angle with 2.5 T1 delay and a 90° flip 
angle with 5 T1 delay, a T2-weighted CPMG, and a T1-weighted 1D NOESY.  Also, an 
inversion recovery sequence was used to obtain spectra for determining T1 values for 
multiple media components and internal standards.  One pure media sample and 
one ’conditioned’ media sample were prepared with 8.15mM formate, 25 mM citrate, 
143 mM imidazole and 890μM TSP.  These compounds were used to observe effects 
of T1 and T2 on peak areas while citrate and imidazole served to measure 
paramagnetic cation effects [24] and pH respectively.  Sensitivity comparisons were 
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made by using the ACD signal-to-noise ratio determination between the various 
pulse sequences. 
 
3.3.5 1H NMR Analysis of Media 
 
Samples were made from 540 µl of media and 60 µl of deuterium oxide 
containing 8.9mM TSP and 81.5mM formate (final sample concentrations 890μM 
and 8.15mM, respectively).  A one-pulse sequence with a 4 sec presaturation pulse 
was used with a sweep width of 4,406.2 Hz, 32K complex datapoints, resulting in an 
acquisition time of 3.72 s and total repletion time of 45 s.  A total of 32 transients 
were obtained resulting in 22 minutes per spectrum.  The FIDs were processed with 
a 0.5 Hz exponential, zero-filled to 64K datapoints, and Fourier transformed into the 
frequency domain.  
Absolute sample concentrations were determined using area under the curve 
(AUC) for selected metabolite peaks normalized to formate concentration and 
adjusted for the proton number associated with the peak of interest.  Consumption 
and production rates were calculated as the millimole difference between the two-
day media changes divided by the number of remaining viable hepatocytes 
inoculated in the BAL or 2D culture dish per hour.  Evaporation differences were 
corrected for by normalizing formate concentrations and applying correction factors 
to all constituents within each individual 2-day sample. 
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3.3.6 NMR Peak Area Determination and Calculation of Error 
 
ACD software (Toronto, Ontario, CA) was used to process and fit the NMR 
data.  A macro was written to process the FIDs as described above and baseline 
corrected using the multi-point baseline correction option.  The spectral peaks were 
fit with both deconvolution, where individual peaks were fit with Lorentzian line 
shapes, and intelligent binning with integration.  The known concentration of TSP 
and formate were used as internal concentration standards.  The accuracy of the 
Mettler model XS205 balance was used in determining the accuracy of the error and 
calculation of NMR accuracy was determined from the literature and known recipe.  
New bottles of formate and TSP were used for the study to insure purity.  Since TSP 
binds to proteins and can result in reduced peak area depending on the pulse 
sequence [18], formate was added as a second concentration to validate the effect of 
TSP binding. 
 
3.3.7 Viability and Functional Assays 
 
Media supernatants were analyzed at 48-hour intervals to monitor liver 
functions, specifically lactate dehydrogenase (LDH) leakage and urea production.  To 
determine the number of live cells remaining in culture, LDH was quantified using a 
Vitros DT60 II chemistry system from Johnson and Johnson (New Brunswick, NJ).  
A standard curve was produced using a known number of cells in a 2 ml volume of 
media, sonicating the cells, and measuring the LDH.  Urea production was 
determined using a diagnostic kit purchased from BioAssay Systems (Hayward, CA).  
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Briefly, a chromogenic reagent forms a colored complex specifically with urea and 
the color was then measured at 520nm using a BioTek microplate reader (Winooski, 
Vermont).  
 
3.3.8 Metabolomic Footprint Mass Balance Model 
 
Metabolic pathway reconstruction was done by entering media components 
into the KEGG or Brenda metabolomic databases (http://www.genome.jp/kegg/) 
and generating connecting pathways [4].  Consumption or production rates were 
calculated based on the NMR data and metabolic mass balance schematics of the 
metabolomic footprint were made at the various time points representing major 
shifts in metabolism throughout the time course. 
 
3.3.9 Microscopy Techniques 
 
The morphology of the cells in 2D cultures were examined using a Leica DMIL 
inverted phase contrast microscope.  Pictures were taken every other day, which 
coincided with media changes.  The BAL cultures were imaged as previously 
described [22].  
 
3.4 Results 
 
Figure 3-2 is a 1H NMR spectrum of the culture media (middle) showing the 
various resonances representing compounds found in the media (see Figure 3-2 
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legend for assignments).  The T1 values of the various resonant peaks in pure media 
are shown in the plot on the bottom of figure 2.  In general, the conditioned media 
decreased the T1 values, and this difference in T1 values is shown at the bottom of the 
plot in Figure 3-2.  There is broadening of the TSP NMR signal that is likely caused 
by the albumin concentration, since albumin binds TSP greatly decreasing its spin-
spin relaxation values [18].  Therefore, formate was used as a concentration standard 
since its peak did not broaden nor did the T1 value change with the addition of 
albumin.  
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Figure 3-2 
NMR metabolites and T1 values 
A) 1H NMR spectra of media exposed to bioreactor containing cells, B) T1 and Delta T1 
values for Fresh Bioreactor Media and Cell Exposed Bioreactor Media as a function of 
Chemical Shift 
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Further comparison of 1H presaturation one-pulse, 1D NOESY (T1-weighted), 
and CPMG (T2-weighted) resulted in similar values for peak areas using either 
integration or deconvolution.  As expected from the T1 values shown in Figure 3-2, 
the T1-weighted 1-D NOESY affected the TSP peak area, decreasing its peak area 
using a 100 ms mixing time (see Methods for sequence parameters).  Overall, 1H 
presaturation one-pulse spectra with a 45º or 90º flip angle had the same signal-to-
noise ratio for a given time.  Since the hormonally-defined or serum-supplemented 
media contains a tenth of the albumin as normal serum, the dramatic effects on TSP 
peak width observed with serum [18] were not seen with culture media.  The T2-
weighted CPMG did not affect the quantification of TSP and no detectable 
paramagnetic load was observed as measured from citrate broadening.  However, 
due to unforeseen effect on T2 values caused by, for example, massive hepatocye 
death causing increased iron load, the simple one-pulse spectrum was chosen as the 
optimum pulse sequence.  Therefore, a simple 1H presaturation one-pulse with 90° 
flip angle and 45 second repetition time (five times the longest T1 value) was 
determined to be the most quantitative pulse sequence.  Comparison of peak fitting 
(i.e. deconvolution) and manual integration resulted in less than 1% difference in 
concentration measures for well resolved peaks.  However, it is critical to manually 
examine the bins from each sample to insure that there are no contaminating peaks 
resulting from unforeseen compounds. 
One interesting discovery due to the use of external standard was a dilution 
factor in the bioreactor in the first media change due to dilution of culture media 
components with the phosphate buffered saline (PBS) rinse procedure. As described 
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in the methods, the bioreactor membrane was ‘wetted’ with ethanol and then rinsed 
two times with PBS, and once with media prior to a final media change before 
inoculation. 
Figure 3-4B shows calculated viable cells by measure of the cumulative media 
LDH, a measure of mortality, over the course of culture (15 days).  In general, the 
LDH activity was slightly higher in 3D bioreactor as compared to the 2D control 
culture.  By measuring the LDH level of seven aliquots of hepatocytes obtained from 
the same isolation used in the bioreactor experiments ranging in cell density from 
65,000 cells/ml to 4.16x106 cells/ml, a calibration line was developed to calculate the 
cell death for each 48 hour media change (Figure 3-3).   
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Figure 3-3 
LDH calibration plot 
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The summation of these LDH values was taken and used to determine the 
total viable cell number and the percent cumulative cell death (Figure 3-4B) based 
upon the equation determined by the calibration plot (Figure 3-3).  These mortality 
values were used to calculate the consumption and production rates of the 3D and 
2D culture as a function of viable cells rather than initial inoculation number.  The 
primary difference other than dimensionality was the oxygen concentration, with 
95% and 20% for the 3D and 2D cultures, respectively.   
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Figure 3-4 
A) Estimated cumulative cell death as a function of study day, B) Estimated viable cells 
 
Figure 3-5 displays the time courses of the major nutrients, glucose (A), 
pyruvate (B), and glutamine (C) consumption rates and lactate production rate (D) 
for the 3D bioreactor and 2D control cultures.  In comparing 2D and 3D culture 
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systems, the glucose and pyruvate consumption rate are fairly similar throughout the 
15 days of culture.  Of particular interest is the difference between glutamine 
consumption rates and lactate production rates as these nutrients are consumed and 
produced by aerobic and anaerobic metabolism, respectively.  Glutamine enters 
directly into the TCA cycle as α-ketoglutarate.  The 3D bioreactor ceases to produce 
lactate by day 5, while continuously consuming glutamine throughout the culture, 
indicating a shift to aerobic metabolism with the TCA cycle dominating energy 
production.  On the other hand, the 2D control has increasing production of lactate, 
demonstrating that the majority of the hepatocytes were relying on anaerobic 
glycolysis. 
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Figure 3-5 
Time course of Glucose, Pyruvate, and Glutamine Consumption (A-C), and Lactate 
Production (D) 
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Figure 3-6 are the urea (A) and alanine (B), production rates in 3D bioreactor 
and 2D control cultures.  The alanine production tracks the urea production and will 
generate ammonia for the urea cycle [25], and after day 8 of culture alanine in fact, is 
consumed.  Alanine also tracks lactate production and is produced in conjunction 
with lactate during anaerobic glycolysis via transamination of pyruvate with 
glutamate [25].  
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Figure 3-6 
Timecourse of Urea and Alanine Production (A,B) 
 
Figure 3-7 are the ethanol concentration (A) and acetate production (B) time 
courses for the 3D bioreactor and 2D control cultures.  Ethanol is discovered in the 
3D bioreactor due to the membrane ‘wetting’ procedure described in the Methods 
section.  The middle hollow fiber is made of polypropylene and require ethanol 
wetting to induce water permeability.  Clearly there should be additional rinsing 
steps with PBS to wash out residual ethanol.  The hepatocytes actively metabolize the 
ethanol to acetate by alcohol dehydrogenase and aldehyde dehydrogenase.  
Interestingly, there is a spike in acetate levels by day 7 in 2D control cultures.  This 
could be due to ethanol metabolism, but there is nearly two orders of magnitude less 
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ethanol in the 2D culture than the amount of acetate that would be created from this 
ethanol.  Under normal physiological conditions, acetate accumulates during fasting 
due to the beta-oxidation of lipids, resulting in two carbon units of acetate.  
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Figure 3-7 
Timecourse of Ethanol Concentration (A), Acetate Production (B) 
 
The various amino acid and nicotinamide did not significantly change over 
the course of the experiment. 
    
3.5 Discussion 
 
Although previous NMR ‘footprinting’ studies of cell culture have been 
performed [1, 3, 8, 12, 17] this is the first example of demonstrating the HTP, 
unbiased nature of NMR spectroscopic analysis especially for tissue engineering.  
Co-resonation of sample compounds can introduce errors that arise when 
concentration measures are performed on spectra that may include contributions 
within a single visible peak that actually arise from two peaks superimposed on each 
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other.  Accurate concentration measures may also be challenged by sample 
contamination, macromolecular content pH, and ionic strength.[26].  Furthermore, 
accuracy and precision issues may arise over the course of a multi-sample study due 
to variation in these same four sample parameters, as well as instrument stability.  
Because the difference in measured concentrations for select compounds in 
standardized media samples was less than 1% for measurements made using 
deconvolution verses manual integration, batch manual integration was used 
exclusively in this study.  The observed difference between these two methods of 
concentration quantification is consistent with reported best practices.[27]  In 
combination with the use of a robotic sample changer, batch binned spectra resulted 
in a high throughput methodology allowing for multiple samples to be rapidly 
processed in a reproducible manner without the need for intensive operator scrutiny 
associated with individual spectrum deconvolution methods.  
The primary obstacle in tissue engineering is the inability of using the most 
common analytical tool of the cell biologist, the microscope, because of the opaque 
properties of the artificial materials used in tissue engineering [22, 28].  Therefore, 
the indirect characterization of tissue function through cell culture media analysis is 
the primary means for tissue engineers to demonstrate bioartificial organ functions.  
The HTP 1H NMR method of media analysis results in an unbiased metabolomic 
‘footprint’ leading to well-informed tissue engineering optimization.  The method 
permits quantitative analysis of extracellular milieu in constant contact with the cell 
culture, which is converted to production or consumption rates.  Although the rates 
shown herein have been used for years in biochemical engineering [29], entering this 
data into a simple biochemical scheme is rarely done and permits an easy 
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interpretation of the complex metabolomic footprint results.  This basic bioenergetic 
scheme of metabolism converts relative mass balance results derived from the 
consumption and production rates to the thickness of arrows along with the rates 
within the biochemical network, giving a rapid overview of carbon flow in the 
bioreactor, similar to other macrokinetic models  
Systemic metabolic changes are evident over the time course of the 
experiment.  In particular, Figure 3-8 is a biochemical schematic representation 
incorporating the consumption and production rates of the 3D and 2D culture 
systems across the two week period.  Initially for the 3D bioreactor (Figure 3-8A), 
the primary energy source was glucose (Figure 3-5).  The bioreactor system appears 
to be less reliant on glutaminolysis for energy during this initial week of culture 
(Figure 3-5).  Glutamine is the primary carbon source for energy in proliferative cells 
in culture [30].  Interestingly there was less build up of lactate which indicates 
aeroebic glycolysis (Figure 3-5).  However, ethanol was discovered in the media 
(Figure 3-7) which is likely an artifact of the initial bioreactor membrane wetting 
process.  Therefore, the details of metabolism are complicated by this high 
concentration of ethanol in the media.  
Ethanol is known to form acetate through the combined actions of ethanol 
dehydrogenase and aldehyde dehydrogenase.  Acetate also increases in the starved 
state, whereby fatty acids undergo β-oxidation increasing the mitochondrial acetate 
concentration [25].  High mitochondrial acetate concentrations inhibits pyruvate 
dehydrogenase (PDH) and increases the activity of pyruvate carboxylase (PC) 
resulting in glucose-derived pyruvate forming oxaloacetate rather than acetyl-CoA 
[31].  This inhibition of pyruvate metabolism by ethanol may have been the cause of 
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the decrease in glucose consumption during this period, as pyruvate is the end 
product of glycolysis and the first step, hexose kinase is inhibited by ATP, which 
would be sufficiently supplied by acetate metabolism [31].  In addition, urea 
production was elevated during this period (Figure 3-6), indicating an abundance of 
ammonia present, likely due to transamination reactions.  The increased glucose-
derived intracellular pyruvate due to PDH inhibition by ethanol-derived AcetylCoA 
would drive the formation of alanine and could be the reason for increased alanine 
production. 
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Figure 3-8 
A) Metabolic scheme for 3D bioreactor, B) Metabolic scheme for 2D gel culture 
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During the second phase of the bioreactor footprint (Figure 3-8A), the 
primary energy source was both glucose and glutamine (Figure 3-5).  There was no 
accumulation of lactate, indicating aeroebic glycolysis (Figure 3-5).  Ethanol and 
acetate had disappeared by day 7 in the media (Figure 3-7) and glucose metabolism 
increased, which would ultimately produce intracellular pyruvate.  This could 
explain why pyruvate remained elevated in the media and the apparent pyruvate 
consumption decreased.  In addition, urea production diminished during this period 
(Figure 3-6). 
The primary energy source for the 2D cultures proved to also be glucose 
during the first three time points measured after culturing (Figure 3-5).  Lactate 
production during this initial phase of the study was elevated as compared to the 3D 
bioreactor indicative of anaerobic metabolism.  Again, ethanol was discovered in the 
media (Figure 3-7) due likely to a process or technician error associated with media 
change.  Lipids likely accumulated as the result of cell debris in the culture dish.  
Metabolism of these membrane breakdown products by the surviving hepatocytes 
resulted in increased acetate levels.  In addition, urea production was observed to be 
nominally above the level of detection during this period (Figure 3-6), however 
transamination reactions were active as production of alanine was observed (Figure 
3-6).  Alanine formation from pyruvate is considered an ammonia detoxication in 
the absence of the urea cycle [25]. 
While glucose was the principal energy source during the second phase of the 
2D culture footprint, unlike the bioreactor, anaerobic glycolysis dominated with 
massive production of lactate (Figure 3-5).  Similar to the bioreactor though, ethanol 
and acetate concentrations diminish over time in the 2D culture (Figure 3-7).  Urea 
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production was consistently low (just above detectable limits) throughout both 
phases of the 2D culture study (Figure 3-6) while alanine production, while erratic, 
was on average greater than that observed in the bioreactor.   
This study demonstrated the power of unbiased NMR spectroscopic analysis 
of culture media for metabolomic phenotyping and experimental quality control in 
tissue engineering. [32].  It is unbiased because all compounds in the media 
containing a 1H will be detected with a 100 µM limit, as long as one of the 
compounds NMR resonances are resolved, resulting in discovery of unexpected 
metabolites—such as ethanol and acetate.  Ethanol and its hepatic metabolite acetate 
would have gone undetected by standard chromatography or spectroscopic methods.   
Critical to the success of this type of study is the use of hormonally defined 
media rather than media using calf serum or other blood products as media 
supplements as such serum-based products cannot offer consistent or reliable 
knowledge of media additives without additional testing.  This lack of reproducible 
initial conditions associated with classic serum-enriched culture media prevents 
precise measurement of consumption and production measures from culture 
systems thus illustrating the significant advantage afforded by hormonally defined 
media in metabolomic studies. 
 Metabolomic interpretation of these data can be used to improve the 
experimental conditions, specifically, oxygen concentration of the mixed gases, 
microenvironmental heterogeneity, and experimental oversights.  The most obvious 
experimental difference that resulted in metabolic effects was oxygen tension.  In 3D 
culture systems 95% oxygen is used versus 20% oxygen (i.e., air) in the 2D culture 
system.  Quality assurance issues that were identified included ethanol rinsing of 
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bioreactor, technician effects, and evaporation associated with the use of dry gases.  
Other areas of tissue culture quality monitoring that may be served by this method 
include detection of low level contaminations by yeast or bacteria, media 
composition consistency, and media component stability.  This 1H NMR method of 
analyzing culture media can be used to obtain near real-time readings of metabolism 
allowing for more rapid optimization of tissue engineered culture conditions.  
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4 Protein Sequestration—a novel solution for protein 
folding NMR studies2 
 
4.1 Introduction 
 
An evolving area in biochemical research exists in the area of protein 
conformation determination using NMR [1, 2].  Recent studies have demonstrated 
that many intracellular proteins have structure which is different from the same 
protein when studied in dilute solution [3-5].  Historically, most protein studies have 
been performed in pure isolate and in vivo conditions allowing for protein 
conformation to change in the absence of the dense milieu of cytoplasmic 
compounds.  Most dilute solution studies are performed at protein concentrations of 
less than 10 g/l when in-cell concentrations can surpass 400 g/l [6].  Understanding 
in vivo conformation under such “crowded” or concentrated conditions is critical in 
testing pharmacokinetics, ligand/receptor interaction, and drug metabolism [7].  
NMR studies differ from other structural determination methods, such as x-
ray crystallography, in that NMR is a non-destructive method which can be used to
                                                   
2  Images and technical support during some portions of the work described in this chapter were 
obtained through cooperative work with Lisa Charlton from the Gary J. Pielak laboratory, UNC-CH  
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target specific compounds when experiments are designed with appropriate isotopic 
nuclei in media constituents for eventual inclusion in protein synthesis.  In 
particular, 15N and 13C can be introduced into nucleic acids which are then 
incorporated into proteins produced by cells which are then observed using NMR.   
Using Heteronuclear Single Quantum Correlation (HSQC), two-dimensional spectra 
can be obtained providing 1H information on one axis and either 15N or 13C 
information on the other axis. Correlation between these two axes can be used to 
determine protein structure.  In particular, 15N HSQC provides unique chemical 
shifts for all amino acids with the exception of proline (the only amino acid having 
no amide proton).  These chemical shifts arise from transference of magnetic 
polarization, applied first to the protons of the sample, to the next adjacent nuclei 
(either 15N or 13C).  The first chemical shift evolves from the 15N or 13C nuclei during 
which a 180° pulse is applied to protons.  The magnetization is then transferred from 
the 15N or 13C nuclei back to the covalently bonded proton after which the proton free 
induction decay is captured while a soft pulse (decoupler) is applied to the non-
proton nuclei to disrupt magnetic coherence [8, 9].  Figure 5.1 illustrates a schematic 
for the HSQC pulse sequence in which the X nuclei channel would be either 15N or 
13C. 
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X
HSQC Pulse Sequence
Decoupler
 
Figure 4-1 
HSQC pulse sequence 
 
 
4.2 Statement of problem 
 
This dissertation does not seek to solve the in-cell conformation of a protein 
through using NMR but instead addresses a challenge that arises in the nature of the 
experiment.  The problem with in vivo NMR occurs when synthesized proteins pass 
out of the cytoplasm and into the extracellular space.  When this occurs, the protein 
conformation may alter as the local environment about the protein is less densely 
concentrated with other agents as compared to the cytoplasmic environment.  When 
this protein “leaking” occurs, two different spectra may arise from the same protein 
based upon the location of the two populations of the protein.  These spectra, 
however, are not truly discrete, but are collected simultaneously confounding 
researchers as to the true conformation of the in-cell protein. 
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4.3 Hypothesis 
 
Because of the comparatively large molecular size, both in terms of sterics and 
molecular weight, it is a reasonable hypothesis to explore whether proteins behave 
differently in alginate encapsulation as compared to the more dynamically moving 
low molecular weight metabolites previously discussed.  A possible outcome that 
might arise through encapsulation of cells synthesizing a protein of interest is that 
the encapsulate would prevent proteins released out of the cells to reach the 
surrounding liquid media outside the encapsulates.  The sequestration of proteins in 
the alginate would therefore have the trapped protein behave as a solid bound 
protein rather than a protein dissolved in liquid phase.  This has particular 
significance for NMR spectroscopy as line broadening occurs for compounds bound 
in hydrogel environments [10].  This line broadening is due the decrease in T2 times 
associated with solid-phase bound analytes.  In short, line broadening can be viewed 
with the following equation: 
2
1  height   halfpeak at  width Line
T
∝
 
 
This equation explains how a reduction in T2 results in substantial line 
broadening.  Line broadening of this sort can be so complete as to diminish the 
magnitude of individual peaks below the ambient noise observed in the spectra.   
With this in mind, a possible solution using the encapsulation process 
emerges.  Encapsulated cells may release protein from the cytoplasm with the 
protein being retained either permanently or temporally within the hydrogel of the 
95 
alginate encapsulation.  If the size of the protein is sufficiently large, the diffusion of 
a temporally bound molecule may be so diminished as to render the molecule 
invisible for the typical multi-hour experiment required in protein NMR. 
Figure 4-2 shows three time points for an NMR experiment in which E. coli 
expressing chymotrypsin inhibitor 2 (CI2)—the inhibitor of chymotrypsin which is a 
digestive enzyme synthesized in the pancreas of numerous mammals and an oft 
studied molecule in the field of protein folding due to its relatively small and 
manageable size of 7.3 kilodaltons (kDa) [11-13].  The left most two images show a 1H 
spectra (top) and 2D 1H-15N spectra (bottom) for media sampled at the beginning of 
the experiment during inoculation of E. coli into an NMR tube.  The expectation 
would be that the media would show no signs of the protein.  However, the spectral 
signatures observed are consistent with the in-cell spectra taken at 1 hour and the 
media extract taken at 2 hours.  In all three cases, CI2 is present revealing the leak of 
protein from within the cytoplasm to the extracellular space. 
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Supernatant , 0 h             Cellular Sample, 1 h          Supernatant, 2 h
 
Figure 4-2 
1D and 2D spectra showing CI2 leak into media 
 
4.4 Methods 
 
To determine the effectiveness of encapsulation as a protein sequestration 
solution, the following experiments were required: 
1. Determine whether electrostatic encapsulation process disrupts 
protein synthesis in E. coli transformed with CI2 plasmid. 
2. Determine whether encapsulated protein produces NMR resonances.  
If the encapsulated protein does not produce NMR resonances, 
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determine whether NMR signature can be regained by disruption of 
encapsulates to return the protein to the liquid dissolved state. 
3. Determine whether encapsulated induced cells expressing 15N enriched 
protein and introduced into an NMR study with the resultant spectra 
displaying no signatures associated with the protein. 
Electrostatic encapsulation was performed in the manner previously 
described in prior chapters.  Alginate stock solutions were prepared in Hanks' 
Balanced Salt Solution (HBSS) due to the absence of any divalent cations that would 
initiate polymerization of alginate and also due to the relative ease with which 2% 
alginate-HBSS solution passes through 0.22 micron filtration—a necessary step to 
remove solids from the stock including biological contaminants larger than the 
specified pore size.   
A second-generation electrostatic encapsulation system was designed building 
on the experiences of three years of studies on the first system previously described.  
The new encapsulation system differed in two areas only.  The power supply used in 
the system was reduced from a maximum output of 30 kV to 8kV with digital 
controls for improved power management as compared to the relatively challenging 
analog voltage needle on the Spellman RHR30PF30 used in the first system due to 
the small operational range of voltages employed in the process.  The new Spellman 
SL8PN10 power supply also provided an additional measure of safety as this unit has 
a current limit setting which controls the maximum current that the power supply 
will output.  By setting the current ceiling to 50 microamps (µA), this power source is 
considerable less dangerous than the non-limited output current which is provided 
by the Spellman RHR30PF30.   
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The second improvement to the encapsulation system was the introduction of 
a flexible, braided ground wire for immersion in the receiving bath.  The prior 
system employed a solid copper wire that was difficult to maneuver due to the 
rigidity of the wire.  In both cases, the ground wires were rated at 600 volts (V) at 5 
ampere (A).   
A B
 
Figure 4-3 
2nd Generation encapsulator 
A) High voltage system with Z-axial pump 
B) 24 gauge angiocatheter shown at 22 mm casting distance 
 
NMR studies were performed on a Varian 600 MHz spectrometer using 5 mm 
tubes.   
Samples were maintained in Luria broth—a widely used nutrient suspension 
appropriate for bacteria propagation and function.  Cultures were treated with 15N 
enriched amino acid Luria broth for the purpose of inclusion in expressed proteins.  
Cultures were centrifuged to allow for collection of cell pellets and to allow for 
standard Luria broth (non-enriched) to be added to cultures prior to NMR studies.  
This step reduces spurious signals that may arise from unused amino acid groups in 
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the broth and proteins bearing isotopic nuclei that may have escaped into the broth 
during culture incubation.  Additionally, magnet shimming on the NMR was 
performed using Luria broth samples. 
In all NMR studies using E. coli encapsulates, the bacteria slurry was treated 
with 2.5 µg/ml chloramphenicol.  Chloramphenicol is an antibiotic that inhibits 
protein synthesis in bacteria.  At a concentration of 2.5 µg/ml, chloramphenicol is 
non-lethal to E. coli but instead presents inhibitory effects on propagation [14].  
Chloramphenicol disrupts the ability of effected bacteria to synthesize proteins.  This 
results in a culture which can not propagate or replace damaged essential proteins.  
For the short temporal nature of the NMR experiments used in these studies, the loss 
of protein expression is not detrimental as the incubation which precedes 
encapsulation allows for over-expression of the protein of interest to the effects of 
the lac operon induction described below.  The effects of chloramphenicol are 
reversible by removal of the agent from culture media [15].  The use of 
chloramphenicol is important for encapsulation studies involving highly proliferative 
bacterial cells to ensure that expansion of cells within an encapsulate does not burst 
the encapsulate and release encapsulated contents into media. 
To improve the signal of proteins of interest while simultaneously limiting 
other innate protein synthesis, protein expression induction was used.  In instances 
where protein expression was induced, isopropyl-β-D-thiogalactosidase (IPTG) was 
added to cultures.  Once introduced into culture, IPTG is not metabolized by bacteria 
and serves to de-activate the lac repressor which was included as a segment in the 
DNA introduced into recombinant DNA (rDNA) transformed into the E. coli coding 
for the expression of target proteins.  Using restriction enzymes to cleave target 
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protein DNA and lac operon DNA, the regulatory DNA found on the 5’ end of the lac 
operon can be annealed with DNA coding for a specific protein.  The resultant rDNA 
is regulated by the lac repressor which prevents RNA polymerase from transcribing 
the DNA on the 5’ end of the regulatory operator.  IPTG binds to the lac repressor 
and disables the binding or the repressor to the regulatory operator allowing for the 
RNA polymerase to transcribe numerous copies of the messenger RNA (mRNA) 
resulting in consistent and predictable over-expression of the protein of interest [16-
18].    
 
4.5 Bacteria viability and function test 
 
Bacteria were passed through a 24 gauge angiocatheter by syringe pump 
displacing 0.714 ml/min while exposed to 3.75 kV of electrostatic force applied 
across a 2.2 cm distance.  Rather than using alginate as a gelling material and CaCl2 
solution as a receiving bath, E. coli were maintained in Luria broth in the syringe and 
passed into a Luria broth receiving bath.  Cells were not induced prior to the sham 
encapsulation.  After the bacteria were collected from the receiving bath using 
centrifugation, IPTG was added to the experimental (sham encapsulation) cohort.  
The bacteria were incubated for 24 hours then treated with sodium dodecyl sulfate 
(SDS) to lyse the bacterial cell wall.  Proteins were collected from a control sample 
through SDS lysis and were run on a poly polyacrylamide gel electrophoresis (PAGE) 
preparation along with the SDS sample from the sham encapsulation.  Gels were 
stained with Coomassie Blue stain to reveal electrophoretically separated proteins 
consistent with practices described by Scopes [19]. 
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Figure 4-4 
SDS-PAGE for E. coli + CI2  
1)Control (no induction)  
2) Sham Encapsulation + IPTG 
 
Figure 4-4 demonstrates that bacteria can not only survive the encapsulation 
process, but also can be subsequently induced by IPTG to express proteins when the 
rDNA sequence for the target protein is associated with the lac operon.    In lane 1, 
the large blur on the left represents stain retained in the start well of the control 
sample.  Dim striping can be observed as tightly spaced parallel lines indicative of 
basal expression of proteins when the lac operon is engaged by the repressor.  By 
contrast, lane 2 shows bright lines down the link of the lane consistent with robust 
protein synthesis following lac operon induction due to the deactivation of the 
repressor in response to IPTG treatment.  Because IPTG is a low molecular weight 
modified sugar (MW = 238.31 g/mol), it should be capable of diffusing into 
encapsulations.  Alternatively, IPTG can be co-encapsulated with cells or cells can be 
induced prior to encapsulation. 
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4.6 Pure protein sequestration study 
 
Encapsulates of 15N CI2 were prepared using a 1:1 mix of 2% HBSS-based 
alginate stock and pure protein dissolved in Luria broth under 3.77 kV electrostatic 
potential.  The intent of this preparation was to observe whether an HSQC pulse 
sequence could detect an enriched protein contained in an alginate encapsulation 
but not contained within the cytoplasm of a cell.   The predicted outcome for this 
experiment would be the observance of no signal for NMR spectra taken with 
encapsulated protein followed by the return of peaks to spectra taken after 
encapsulates were disrupted and the protein contained within returns to the liquid 
dissolved state. 
The HSQC performed on the encapsulates of pure CI2 protein did not 
demonstrate any of the peaks typical of CI2.  Encapsulates were treated next with 
400 µl of 500 mM ethylene diamine tetraacetic acid (EDTA).  EDTA, like sodium 
citrate as previously described, chelates divalent cations such as Ca+2 [20].  The 
chelation of calcium results in the disintegration of encapsulates which returns the 
15N enriched CI2 to the liquid dissolved state.  In this study, the anticipated peaks 
associated with CI2 were not detected using HSQC with 256 transients.  This 
experiment was repeated three times and never achieved the predicted outcome.  
The CI2 was tested using SDS-PAGE.  The CI2 demonstrated the classic banding 
associated with CI2 in the PAGE.  However, SDS-PAGE is insensitive to the 
difference between nuclei differing only by one neutron.  Therefore, SDS-PAGE 
cannot be trusted to positively identify a protein as being 15N enriched.  At the time 
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of this publication, pure protein sequestration experiments were still being 
performed.         
 
4.7 In-cell NMR of α-synuclein using alginate encapsulates 
 
If the findings of the bacteria functional tests and pure protein sequestration 
study are reliable, encapsulates of bacteria induced to express an enriched protein 
should produce HSQC resonances that are associated with the in-cell protein only.  
Any protein that leaks out of the cytoplasm of the bacteria and into the surrounding 
encapsulate should not produce resonances as predicted by the previously observed 
outcomes. 
To test these predictions, E. coli transformed to express α-synuclein and 
induced with IPTG were encapsulated in alginate and allowed to incubate for 24 
hours in 15N enriched Luria broth.  The choice of α-synuclein as the study protein is 
significant in that this protein is expressed in neuronal cells and aggregates to form 
fibrils and Lewy bodies in dopaminergic neurons which can evolve into Parkinson’s 
disease [21-23].  At 140 amino acid residues and 14 kDa, α-synuclein is noteworthy 
for the variety of conformations that the molecule can assume especially when 
missense mutations which can contribute to early onset Parkinson’s are considered 
[24].  This leads to the consideration of possible therapeutics for Parkinson’s based 
on corrupt versions of α-synuclein or similar peptides which inhibit the formation of 
fibrils and Lewy bodies [25, 26]. 
Following incubation in enriched media, encapsulates were loaded into an 
NMR tube with non-enriched Luria broth.  An HSQC was conducted on the 
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encapsulates.  Figure 4-5A shows the 2D HSQC spectrum for the encapsulated E. 
coli.  The HSQC spectrum clearly shows resonances consistent with previously 
recorded α-synuclein spectra.   
Because the HSQC transfers magnetic polarization from protons to covalently 
bonded 15N and then back to the proton, a 1D proton spectra extracted from the 
HSQC is sufficient to observe the presence or absence of resonances arising from a 
single chemical entity.  Figure 4-5B shows the first increment of the HSQC which is a 
1-D proton spectrum of the supernatant taken 26 hours after encapsulates were 
inoculated into the NMR tube.  This spectrum shows only slight downfield peaks 
which would indicate minute loss of enriched protein into the supernatant.  These 
downfield peaks are only slightly above background noise and would contribute 
signal to the in-cell spectrum that would be insignificant when compared to the 
highly retained in-cell protein.  As the evolution of signal in the supernatant study is 
positively correlated with time, experiments conducted more rapidly would 
experience supernatant contributed signal in the HSQC in proportion to the 
experiment duration.  
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A B
 
Figure 4-5 
NMR spectra for in-cell α-synuclein E. coli study 
A) Encapsulated HSQC     
B) Supernatant at 26 hours 
 
The experiment was performed again using E. coli transformed to express 
CI2.  The E. coli were induced and incubated in 15N enriched Luria broth prior to 
encapsulation and transferred to standard (non-enriched) Luria broth for the NMR 
studies.  Figure 4-6A shows the proton spectrum taken from the HSQC study 
performed on the encapsulated E. coli.  The resonances observed in the 5 – 6 ppm 
region are associated with water which is irregular due to the inhomogeneity of the 
sample—encapsulates immersed in Luria broth presenting solid hydrogels blended 
with an aqueous liquid.    Figure 4-6A does not show peaks associated with CI2 in the 
first increment.  The predicted outcome for this experiment was that classic CI2 
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peaks would be observed from the enriched intracellular protein within the 
encapsulates.  
A B
 
Figure 4-6 
Proton spectrum for in-cell CI2 E. coli study  
A) Encapsulated protein 
B) Post-EDTA treatment 
 
Figure 4-6B shows a similar proton spectrum taken from the first increment 
of an HSQC study performed on the same sample as in Figure 4-6A following 
removal of liquid media and treatment of encapsulates with 400µl of 500 mM EDTA.  
The pronounced downfield peaks arise from the intracellular CI2 following the 
release of bacteria from the alginate encapsulates. 
In this demonstration, resonances were not observed for intracellular 
enriched CI2 contained in alginate encapsulates but were restored by removing the 
alginate encapsulates from around the contained bacteria.  This result is in 
opposition to the previously described α-synuclein study.  Continuing studies will be 
required to fully characterize the observed phenomena and the application of these 
findings to in-cell protein conformation determination using NMR. 
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4.8 Discussion 
In summary, for large proteins, alginate encapsulation in conjunction with in-
cell NMR may be a robust solution for reducing or removing extracellular  or 
“leaked” protein contributions to NMR spectra.  At the time of this publication, 
however, confounding experimental outcomes to assess such utility are inconclusive.  
An additional opportunity for in-cell experiment refinement can be achieved using 
alginate encapsulations in conjunction with superfused media.  Because E. coli has 
an elongated cylindrical architecture with the long axis being 2 µm and the diameter 
measuring approximately 500 nm, free bacteria floating in solution could not be 
maintained in a flow environment.  Encapsulation would allow for the bacteria to be 
held static in position while the moving media would maintain uniform pH and 
respiratory substrates while providing for removal of metabolic wastes.  This flow 
would also carry off any proteins that slipped past the sequestration provided by 
encapsulates virtually eliminating signals that would otherwise arise from the leaked 
proteins. 
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5 Continuing Studies & Opportunities for Future 
Development 
 
Further work will need to explore the significant contributions that 
extracellular matrices (ECM) have on metabolic functionality.  While alginate is well 
tolerated by recipients of implants, it may not provide the best physiological match 
for hepatocytes especially when compared to collagens and other native matrices.  
Methodologically though, the electrostatic process should continue to be the 
encapsulation method for future studies due to its ability to reproducibly generate 
uniform encapsulations while exposing the cells contained in the gelling media to 
low shear stress—a feature that is particularly important for hepatocytes. 
 
5.1 NMR Compatible Bioreactors 
 
Continuing improvements in electrostatic encapsulations will provide several 
opportunities for further development in both basic research and clinical 
applications.  In the area of basic research, cell encapsulations may be introduced 
into NMR compatible bioreactors for use in real-time metabolic studies.  
Experiments of this variety would allow for cells to be exposed to chemical stress 
while metabolic functionality is monitored by NMR interrogation over a period of 
time.  The cells in encapsulations would be held in a fixed volume region of an NMR
 111 
tube while a superfusion system would allow for media flow to be delivered across 
the encapsulate matrix. 
NMR compatible bioreactor experiments will allow for the detection of 
metabolites within the cell.  This is of particular importance because some charged 
species cannot pass from the cytoplasm into the extracellular space thereby 
preventing detection in media-only analysis.  The media analysis can demonstrate 
viability and functionality but a more complete understanding of metabolic 
outcomes will require NMR analysis of in vitro cell preparations. 
 
Figure 5-1 
First generation NMR compatible bioreactor 
 
 
Improved NMR compatible bioreactor designs have already emerged and as 
of this publication are being tested for use in 1H and 31P studies. 
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Figure 5-2 
Second generation NMR compatible bioreactor 
 
 
5.2 Encapsulate survival studies for NMR compatible 
bioreactors 
 
While incell NMR has yet to produce successful spectra, studies to determine 
cell viability and effects of flow environments on encapsulate architecture have been 
performed.  Confocal microscopy was used to image encapsulates of murine 
hepatocytes at 1 day, 5 day, and 10 day times points.  Encapsulates were kept 
incubated in DMEM with 10% fetal bovine serum (FBS), penicillin, streptomycin, 
and dexamethasone.  Images were prepared using an LSM 510 microscope.  Tetra-
methyl rhodamine methyl ester perchlorate (TMRM) was used to image cells 
containing mitochondria having a membrane potential [1].  Figure 5-3A shows an 
equatorial confocal slice of several encapsulates with cells nearest the alginate 
boundary fluorescing.   Confocal stacks reveal that at all confocal planes residing 
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between the objective and the equator of encapsulates fluoresce suggesting that the 
absence of uniform fluorescence is due to either excitation light or emission light 
being obscured by cells laying between a given confocal plane and the detector.  At a 
cell density of 20 million cells/ml, this type of optical phenomenon is to be expected 
and explains why interior cells are not observed to fluoresce as observed and 
discussed previously.  Figure 5-3B shows the grainy interior of a single hepatocyte 
contained within an encapsulate.  Of particular importance is the uneven 
intracellular distribution of the emission which is consistent with discrete 
mitochondria maintaining an electric potential.  The image also reveals the typical 
geometry of mitochondria to be elliptical. 
A B
 
Figure 5-3 
A) Encapsulates at 24 hours (10x)  
B) Encapsulated cell at 24 hours (63x) 
 
Encapsulates were inspected on day 5 of the study to observe the macro 
structure of encapsulates and cell viability using TMRM.  Figure 5-4 presents images 
that are indicative of encapsulates (A) and viable cells (B) that are in tact without 
significant change in either shape or size. 
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Figure 5-4 
A) Encapsulates at 5 days (10x)  
B) Encapsulated cell at 5 days (63x) 
 
Encapsulations were divided into two groups on day 5.  The first group was 
returned to standard incubation while the second group was introduced into the 
second generation NMR compatible bioreactor.  The bioreactor system was 
comprised of a closed loop pump which delivered DMEM (consistent with the 
formulation described above) at a rate of 2ml/min.  The flow passed through a gas 
exchange module (GEM) in which a separate closed loop recirculating water bath 
brought the media temperature to 37 C while allowing gas exchange across a 
spiraling length of silastic tubing.  Figure 5-5 illustrates the GEM with labeled parts.  
The system was established with 125 ml of media and set for recirculation of the 
media during the experiment.  Approximately 2.5 ml of encapsulates at a density of 
20 million murine cells/ml were inoculated into the 10 mm bioreactor tube and were 
retained there throughout the experiment by filter baffles which allow for media flow 
but retain the encapsulates fixed in place within the tube. 
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Figure 5-5 
Bioreactor with Gas Exchange Module 
 
Five days after bioreactor inoculation, encapsulates were recovered from the 
10 mm bioreactor tube and were imaged confocally along with encapsulates that 
remained in incubation (control).  Figure 5-6 shows images of the 10 day incubated 
encapsulates (A) and the bioreactor inoculated encapsulates which were maintained 
in an incubator for days 1-5 then transferred to the bioreactor for days 6-10 (B).   
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Figure 5-6  
Day 10 images (10x)  
A) Control B) Bioreactor 
 
Images of individual cells taken on day 10 show uneven distribution of TMRM 
in both the control and bioreactor samples.  In some instances, mitochondria in the 
control encapsulates were observed to be enlarged and round in shape rather than 
elliptical in shape.  Figure 5-7 shows typical cells as observed on day 10 using a 63x 
objective. 
A B
 
Figure 5-7 
Day 10 images (63x)  
A) Control B) Bioreactor 
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To verify the TMRM observed response, MitoTracker® Green  (Molecular 
Probes, M7514, Eugene, OR) was applied to bioreactor encapsulates on day 10.  A 
sample of these encapsulates was then added to non-labeled encapsulates to allow 
for fluorescent signals arising from fluoroprobe emissions to be differentiated from 
auto-fluorescence which is a common challenge for hepatocyte imaging.  Figure 5-8A 
shows a labeled encapsulate to the left of the image in a frame containing numerous 
auto-fluorescing encapsulates as observed by the difference in emission intensity.   
The individual cells observed in Figure 5-8B show discrete mitochondria verifying 
the TMRM observations.   
These images collectively show that the encapsulated cells can be maintained 
in stable encapsulates for up to five days while subjected to constant flow.  This is the 
first demonstration of both the long term encapsulate architectural integrity and the 
viability of hepatocytes within encapsulates under flow conditions.  Both of these 
findings are important steps in the development of NMR compatible bioreactor 
experiments which will require multi-hour or multi-day study times to acquire 31P 
signals and other isotopically labeled compounds due to the challenges associated 
with capturing spectra with lower signal-to-noise measurements. 
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Figure 5-8 Day 10 images  
A) Bioreactor (10x) 
B) Bioreactor (63x) 
 
In an effort to improve signal-to-noise quality of the spectra arising from in-
cell NMR studies while limiting sample time required for each experiment, it is 
important to maximize the cell density within encapsulates to provide maximum 
signal.  Such measures must be taken while simultaneously ensuring that cell 
viability within densely packed encapsulates is not sacrificed.  At the time of this 
publication, uniform spherical encapsulates having a cell density of 35 million 
cells/ml encapsulation stock had been achieved.  Figure 5-9 shows a fifteen frame 
series of confocal images taken 24 hours after encapsulation using 1.1 µM TMRM.  
Continued research should be carried out to determine viability duration and 
function for encapsulates at such high cell densities.  
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Figure 5-9 
Murine Encapsulates (20x) 
 
Figure 5-10 illustrates the spatial difference between encapsulates prepared at 
20 million cells/ml and 35 million cells/ml.  Both images were obtained using a 20x 
objective and 1.1 µM TMRM.  While both samples were prepared using the same 
voltage (3.7 kV) and the same preparations of alginate, storage media, and CaCl2 
stock, the average diameter of the encapsulates differed by 3.7%.  The encapsulates 
prepared with 20 million cells/ml had an average diameter of  599 µm while the 
encapsulates prepared with 35 million cells/ml had an average diameter of 622 µm.  
This difference is due to the viscosity or thickening of the stock which occurs as the 
cell density is increased.  Future projects utilizing encapsulates should take care to 
consider encapsulation diameter effects induced by cell density.  An increase in 
electrostatic voltage which reduces encapsulate diameter can correct for this 
difference. 
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Figure 5-10 
A) 35 million cells/ml 
B) 20 million cells/ml 
 
Increasing cell density should continue to be a priority in this field of study as 
NMR signal doubles as cell density doubles while noise is diminished by the square-
root of the number of transients (n) which can be thought of as time.  Therefore, a 
doubling of cell density improves signal-to-noise such that an equivalent experiment 
can be performed in one-quarter the time.  Such signal-noise-improvements have 
profound implications for accurately measuring dynamic metabolic events and on 
total experimental cost.  
 
5.3 Cryopreservation Methodology Development 
 
Additional work in the area of cryopreservation of encapsulations should be 
explored.  Techniques using vitrification solutions to reduce the damage due to water 
expansion during freezing may be employed in a manner consistent with methods 
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used to cryopreserve embryos.  Such methods would replace water with glycerol and 
ethylene glycol solutions through a gradient process as a prelude to freezing [2]. 
 
5.4 Mass Transfer Studies 
 
Questions regarding mass transfer in encapsulations should be further 
explored through modeling and compared to conventional gels.   Furthermore, such 
findings will play an important role in determining the practical utility of the NMR 
compatible bioreactor shown above. 
 
5.5 Metabolic Studies using Isotopic Labeled Media 
Components 
 
Through the use of media constituents such as glucose or glutamine labeled 
with isotopic nitrogen or carbon atoms (15N or 13C), metabolic products can be 
discretely tracked from the original source through a metabolic pathway using 
isotopic based NMR.  This method may also by used to observe changes in ATP over 
the time course of experiments by using.  Similar tracking using non-isotopic 
labeling can be achieved by using fluorine replacement of protons on a compound of 
interest added to the media followed by fluorine NMR.  
 
 122 
5.6 Microscopy and Histology Studies 
 
Further microscopy and histological work should focus attention on the 
migration of cells within encapsulations and in adjacent encapsulations resulting in 
proximal cell-to-cell signaling.  Determination of benefits derived from these 
interactions may serve to advance both clinical and basic research opportunities in 
the future. 
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5.7 Endnotes 
 
1. Haugland, R., Handbook of Fluorescent Probes and Research Products, 9th 
Edition. 2002, Molecular Probes, Inc.: Eugene, OR. 
2. Kasai, M., Mukaida, T., Cryopreservation of animal and human embryos by 
vitrification. Reproductive BioMedicine Online, 2004. 9(2): p. 164-170. 
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